nodes	percent_of_prediction	percent_of_DWPC	metapath
Imipramine—Carbamazepine—epilepsy syndrome	0.125	0.52	CrCtD
Imipramine—Oxcarbazepine—epilepsy syndrome	0.115	0.479	CrCtD
Imipramine—panic disorder—Diazepam—epilepsy syndrome	0.069	0.425	CpDpCtD
Imipramine—KCND2—epilepsy syndrome	0.0676	0.403	CbGaD
Imipramine—endogenous depression—Valproic Acid—epilepsy syndrome	0.0515	0.317	CpDpCtD
Imipramine—panic disorder—Clonazepam—epilepsy syndrome	0.0418	0.258	CpDpCtD
Imipramine—CHRM3—epilepsy syndrome	0.0186	0.111	CbGaD
Imipramine—CHRM1—epilepsy syndrome	0.0173	0.103	CbGaD
Imipramine—CHRM2—epilepsy syndrome	0.0142	0.0843	CbGaD
Imipramine—HTR7—epilepsy syndrome	0.0141	0.0839	CbGaD
Imipramine—Epinastine—Carbamazepine—epilepsy syndrome	0.0112	0.073	CrCrCtD
Imipramine—Epinastine—Oxcarbazepine—epilepsy syndrome	0.0103	0.0673	CrCrCtD
Imipramine—SLC6A4—epilepsy syndrome	0.00922	0.0549	CbGaD
Imipramine—CYP2C18—Clobazam—epilepsy syndrome	0.00912	0.0576	CbGbCtD
Imipramine—CYP2C19—epilepsy syndrome	0.00874	0.052	CbGaD
Imipramine—HTR2A—epilepsy syndrome	0.00709	0.0422	CbGaD
Imipramine—Carbamazepine—Phenytoin—epilepsy syndrome	0.00698	0.0454	CrCrCtD
Imipramine—Mianserin—Oxcarbazepine—epilepsy syndrome	0.00696	0.0454	CrCrCtD
Imipramine—CYP2C18—Phenytoin—epilepsy syndrome	0.00678	0.0428	CbGbCtD
Imipramine—CYP2D6—epilepsy syndrome	0.00648	0.0386	CbGaD
Imipramine—CYP2C18—Propofol—epilepsy syndrome	0.00632	0.0399	CbGbCtD
Imipramine—CYP2C18—Phenobarbital—epilepsy syndrome	0.00604	0.0381	CbGbCtD
Imipramine—Carbamazepine—Oxcarbazepine—epilepsy syndrome	0.00593	0.0386	CrCrCtD
Imipramine—Nortriptyline—Oxcarbazepine—epilepsy syndrome	0.00593	0.0386	CrCrCtD
Imipramine—CYP2C18—Diazepam—epilepsy syndrome	0.00573	0.0361	CbGbCtD
Imipramine—Cyclobenzaprine—Carbamazepine—epilepsy syndrome	0.00546	0.0356	CrCrCtD
Imipramine—Oxcarbazepine—Carbamazepine—epilepsy syndrome	0.00546	0.0356	CrCrCtD
Imipramine—Doxepin—Oxcarbazepine—epilepsy syndrome	0.00535	0.0349	CrCrCtD
Imipramine—Desipramine—Carbamazepine—epilepsy syndrome	0.00502	0.0327	CrCrCtD
Imipramine—Oxcarbazepine—Clobazam—epilepsy syndrome	0.00483	0.0314	CrCrCtD
Imipramine—ABCB1—epilepsy syndrome	0.00463	0.0275	CbGaD
Imipramine—Desipramine—Oxcarbazepine—epilepsy syndrome	0.00463	0.0301	CrCrCtD
Imipramine—Ethopropazine—Carbamazepine—epilepsy syndrome	0.00454	0.0296	CrCrCtD
Imipramine—CYP2C18—Valproic Acid—epilepsy syndrome	0.00451	0.0285	CbGbCtD
Imipramine—Amitriptyline—Oxcarbazepine—epilepsy syndrome	0.00451	0.0294	CrCrCtD
Imipramine—Oxcarbazepine—Diazepam—epilepsy syndrome	0.00449	0.0292	CrCrCtD
Imipramine—Trimipramine—Carbamazepine—epilepsy syndrome	0.00444	0.0289	CrCrCtD
Imipramine—Dimetacrine—Carbamazepine—epilepsy syndrome	0.00425	0.0277	CrCrCtD
Imipramine—Trimipramine—Oxcarbazepine—epilepsy syndrome	0.00409	0.0267	CrCrCtD
Imipramine—Methdilazine—Carbamazepine—epilepsy syndrome	0.00399	0.026	CrCrCtD
Imipramine—Dimetacrine—Oxcarbazepine—epilepsy syndrome	0.00391	0.0255	CrCrCtD
Imipramine—Clomipramine—Clobazam—epilepsy syndrome	0.00383	0.025	CrCrCtD
Imipramine—Promethazine—Carbamazepine—epilepsy syndrome	0.00377	0.0245	CrCrCtD
Imipramine—Alimemazine—Carbamazepine—epilepsy syndrome	0.0037	0.0241	CrCrCtD
Imipramine—Methdilazine—Oxcarbazepine—epilepsy syndrome	0.00368	0.024	CrCrCtD
Imipramine—CYP2E1—Felbamate—epilepsy syndrome	0.00359	0.0226	CbGbCtD
Imipramine—CYP2E1—Trimethadione—epilepsy syndrome	0.00359	0.0226	CbGbCtD
Imipramine—Clomipramine—Diazepam—epilepsy syndrome	0.00357	0.0232	CrCrCtD
Imipramine—Promethazine—Oxcarbazepine—epilepsy syndrome	0.00347	0.0226	CrCrCtD
Imipramine—Alimemazine—Oxcarbazepine—epilepsy syndrome	0.00341	0.0222	CrCrCtD
Imipramine—Chlorpromazine—Clobazam—epilepsy syndrome	0.00339	0.0221	CrCrCtD
Imipramine—CYP2B6—Fosphenytoin—epilepsy syndrome	0.00333	0.021	CbGbCtD
Imipramine—Diphenhydramine—Phenytoin—epilepsy syndrome	0.00321	0.0209	CrCrCtD
Imipramine—Promazine—Carbamazepine—epilepsy syndrome	0.00319	0.0208	CrCrCtD
Imipramine—SLC22A1—Midazolam—epilepsy syndrome	0.00315	0.0199	CbGbCtD
Imipramine—CYP2E1—Clonazepam—epilepsy syndrome	0.00305	0.0193	CbGbCtD
Imipramine—Prochlorperazine—Clobazam—epilepsy syndrome	0.00305	0.0198	CrCrCtD
Imipramine—Promazine—Oxcarbazepine—epilepsy syndrome	0.00294	0.0191	CrCrCtD
Imipramine—CYP2B6—Clobazam—epilepsy syndrome	0.00288	0.0182	CbGbCtD
Imipramine—CYP3A7—Carbamazepine—epilepsy syndrome	0.00251	0.0158	CbGbCtD
Imipramine—CYP3A7-CYP3A51P—Carbamazepine—epilepsy syndrome	0.00251	0.0158	CbGbCtD
Imipramine—CYP2E1—Rufinamide—epilepsy syndrome	0.00249	0.0157	CbGbCtD
Imipramine—CYP2C19—Oxcarbazepine—epilepsy syndrome	0.00242	0.0153	CbGbCtD
Imipramine—CYP2B6—Carbamazepine—epilepsy syndrome	0.00239	0.0151	CbGbCtD
Imipramine—CYP3A7—Phenytoin—epilepsy syndrome	0.00225	0.0142	CbGbCtD
Imipramine—CYP3A7-CYP3A51P—Phenytoin—epilepsy syndrome	0.00225	0.0142	CbGbCtD
Imipramine—CYP2C19—Felbamate—epilepsy syndrome	0.00225	0.0142	CbGbCtD
Imipramine—CYP2C19—Trimethadione—epilepsy syndrome	0.00225	0.0142	CbGbCtD
Imipramine—CYP2B6—Primidone—epilepsy syndrome	0.00223	0.0141	CbGbCtD
Imipramine—CYP2B6—Phenytoin—epilepsy syndrome	0.00214	0.0135	CbGbCtD
Imipramine—ABCB1—Levetiracetam—epilepsy syndrome	0.00213	0.0135	CbGbCtD
Imipramine—CYP2C19—Fosphenytoin—epilepsy syndrome	0.00211	0.0133	CbGbCtD
Imipramine—CYP2E1—Propofol—epilepsy syndrome	0.00203	0.0128	CbGbCtD
Imipramine—CYP3A7—Phenobarbital—epilepsy syndrome	0.00201	0.0127	CbGbCtD
Imipramine—CYP3A7-CYP3A51P—Phenobarbital—epilepsy syndrome	0.00201	0.0127	CbGbCtD
Imipramine—CYP2B6—Propofol—epilepsy syndrome	0.002	0.0126	CbGbCtD
Imipramine—CYP3A7—Midazolam—epilepsy syndrome	0.00198	0.0125	CbGbCtD
Imipramine—CYP3A7-CYP3A51P—Midazolam—epilepsy syndrome	0.00198	0.0125	CbGbCtD
Imipramine—CYP2E1—Phenobarbital—epilepsy syndrome	0.00194	0.0122	CbGbCtD
Imipramine—CYP2B6—Phenobarbital—epilepsy syndrome	0.00191	0.0121	CbGbCtD
Imipramine—CYP2E1—Midazolam—epilepsy syndrome	0.00191	0.0121	CbGbCtD
Imipramine—CYP3A7—Diazepam—epilepsy syndrome	0.0019	0.012	CbGbCtD
Imipramine—CYP3A7-CYP3A51P—Diazepam—epilepsy syndrome	0.0019	0.012	CbGbCtD
Imipramine—CYP2B6—Midazolam—epilepsy syndrome	0.00188	0.0119	CbGbCtD
Imipramine—CYP2E1—Diazepam—epilepsy syndrome	0.00184	0.0116	CbGbCtD
Imipramine—CYP2C19—Clobazam—epilepsy syndrome	0.00183	0.0116	CbGbCtD
Imipramine—CYP2B6—Diazepam—epilepsy syndrome	0.00181	0.0114	CbGbCtD
Imipramine—CYP2C19—Carbamazepine—epilepsy syndrome	0.00152	0.00959	CbGbCtD
Imipramine—ABCB1—Clobazam—epilepsy syndrome	0.00148	0.00934	CbGbCtD
Imipramine—CYP2B6—Valproic Acid—epilepsy syndrome	0.00143	0.00901	CbGbCtD
Imipramine—ABCB1—Lamotrigine—epilepsy syndrome	0.00142	0.00899	CbGbCtD
Imipramine—CYP2C19—Primidone—epilepsy syndrome	0.00142	0.00895	CbGbCtD
Imipramine—CYP1A2—Carbamazepine—epilepsy syndrome	0.0014	0.00885	CbGbCtD
Imipramine—CYP2C19—Phenytoin—epilepsy syndrome	0.00136	0.0086	CbGbCtD
Imipramine—CYP1A2—Primidone—epilepsy syndrome	0.00131	0.00826	CbGbCtD
Imipramine—CYP2C19—Propofol—epilepsy syndrome	0.00127	0.00802	CbGbCtD
Imipramine—ABCB1—Carbamazepine—epilepsy syndrome	0.00123	0.00774	CbGbCtD
Imipramine—CYP2C19—Phenobarbital—epilepsy syndrome	0.00121	0.00766	CbGbCtD
Imipramine—CYP1A2—Propofol—epilepsy syndrome	0.00117	0.0074	CbGbCtD
Imipramine—CYP3A4—Oxcarbazepine—epilepsy syndrome	0.00117	0.00738	CbGbCtD
Imipramine—CYP2C19—Diazepam—epilepsy syndrome	0.00115	0.00727	CbGbCtD
Imipramine—CYP2C19—Zonisamide—epilepsy syndrome	0.00112	0.00709	CbGbCtD
Imipramine—CYP1A2—Phenobarbital—epilepsy syndrome	0.00112	0.00707	CbGbCtD
Imipramine—ABCB1—Phenytoin—epilepsy syndrome	0.0011	0.00694	CbGbCtD
Imipramine—CYP3A4—Felbamate—epilepsy syndrome	0.00109	0.00686	CbGbCtD
Imipramine—CYP3A4—Trimethadione—epilepsy syndrome	0.00109	0.00686	CbGbCtD
Imipramine—CYP1A2—Diazepam—epilepsy syndrome	0.00106	0.0067	CbGbCtD
Imipramine—CYP3A4—Fosphenytoin—epilepsy syndrome	0.00102	0.00645	CbGbCtD
Imipramine—ABCB1—Phenobarbital—epilepsy syndrome	0.00098	0.00618	CbGbCtD
Imipramine—ABCB1—Midazolam—epilepsy syndrome	0.000966	0.0061	CbGbCtD
Imipramine—CYP2D6—Propofol—epilepsy syndrome	0.000966	0.0061	CbGbCtD
Imipramine—ABCB1—Diazepam—epilepsy syndrome	0.000929	0.00586	CbGbCtD
Imipramine—CYP3A4—Clonazepam—epilepsy syndrome	0.000924	0.00583	CbGbCtD
Imipramine—CYP2C19—Valproic Acid—epilepsy syndrome	0.000907	0.00573	CbGbCtD
Imipramine—CYP3A4—Clobazam—epilepsy syndrome	0.000886	0.00559	CbGbCtD
Imipramine—CYP1A2—Valproic Acid—epilepsy syndrome	0.000837	0.00528	CbGbCtD
Imipramine—CYP2C19—Topiramate—epilepsy syndrome	0.000819	0.00517	CbGbCtD
Imipramine—CYP3A4—Rufinamide—epilepsy syndrome	0.000753	0.00476	CbGbCtD
Imipramine—CYP3A4—Carbamazepine—epilepsy syndrome	0.000734	0.00463	CbGbCtD
Imipramine—CYP3A4—Primidone—epilepsy syndrome	0.000685	0.00433	CbGbCtD
Imipramine—CYP3A4—Phenytoin—epilepsy syndrome	0.000659	0.00416	CbGbCtD
Imipramine—CYP3A4—Propofol—epilepsy syndrome	0.000614	0.00388	CbGbCtD
Imipramine—CYP3A4—Phenobarbital—epilepsy syndrome	0.000587	0.00371	CbGbCtD
Imipramine—CYP3A4—Acetazolamide—epilepsy syndrome	0.000587	0.00371	CbGbCtD
Imipramine—CYP3A4—Midazolam—epilepsy syndrome	0.000579	0.00365	CbGbCtD
Imipramine—SLC6A2—locus ceruleus—epilepsy syndrome	0.000562	0.0264	CbGeAlD
Imipramine—CYP3A4—Diazepam—epilepsy syndrome	0.000556	0.00351	CbGbCtD
Imipramine—CYP3A4—Zonisamide—epilepsy syndrome	0.000543	0.00343	CbGbCtD
Imipramine—HTR7—locus ceruleus—epilepsy syndrome	0.000541	0.0255	CbGeAlD
Imipramine—CYP3A4—Valproic Acid—epilepsy syndrome	0.000439	0.00277	CbGbCtD
Imipramine—HTR7—vagus nerve—epilepsy syndrome	0.000414	0.0195	CbGeAlD
Imipramine—CYP3A4—Topiramate—epilepsy syndrome	0.000396	0.0025	CbGbCtD
Imipramine—KCND2—hindbrain—epilepsy syndrome	0.000351	0.0165	CbGeAlD
Imipramine—HTR6—ganglion—epilepsy syndrome	0.000344	0.0162	CbGeAlD
Imipramine—HTR2A—locus ceruleus—epilepsy syndrome	0.000338	0.0159	CbGeAlD
Imipramine—SLC6A3—telencephalic ventricle—epilepsy syndrome	0.00033	0.0155	CbGeAlD
Imipramine—HTR2C—telencephalic ventricle—epilepsy syndrome	0.000319	0.015	CbGeAlD
Imipramine—HTR7—pons—epilepsy syndrome	0.000312	0.0147	CbGeAlD
Imipramine—KCND3—hindbrain—epilepsy syndrome	0.000306	0.0144	CbGeAlD
Imipramine—SLC6A2—autonomic nervous system—epilepsy syndrome	0.000298	0.0141	CbGeAlD
Imipramine—HTR7—autonomic nervous system—epilepsy syndrome	0.000288	0.0135	CbGeAlD
Imipramine—HTR2A—cerebellar cortex—epilepsy syndrome	0.000275	0.013	CbGeAlD
Imipramine—HTR1A—telencephalic ventricle—epilepsy syndrome	0.000269	0.0126	CbGeAlD
Imipramine—HTR2A—vagus nerve—epilepsy syndrome	0.000258	0.0122	CbGeAlD
Imipramine—HTR7—telencephalic ventricle—epilepsy syndrome	0.000257	0.0121	CbGeAlD
Imipramine—DRD2—telencephalic ventricle—epilepsy syndrome	0.000243	0.0114	CbGeAlD
Imipramine—SLC6A3—ganglion—epilepsy syndrome	0.000205	0.00967	CbGeAlD
Imipramine—SLC22A1—ganglion—epilepsy syndrome	0.000202	0.00953	CbGeAlD
Imipramine—KCND2—brainstem—epilepsy syndrome	0.000201	0.00946	CbGeAlD
Imipramine—HTR2C—ganglion—epilepsy syndrome	0.000199	0.00935	CbGeAlD
Imipramine—HTR2A—pons—epilepsy syndrome	0.000195	0.00916	CbGeAlD
Imipramine—KCND2—forebrain—epilepsy syndrome	0.000194	0.00913	CbGeAlD
Imipramine—SLC22A3—tongue—epilepsy syndrome	0.000191	0.00901	CbGeAlD
Imipramine—SLC6A4—ganglion—epilepsy syndrome	0.000188	0.00887	CbGeAlD
Imipramine—HTR2A—autonomic nervous system—epilepsy syndrome	0.000179	0.00845	CbGeAlD
Imipramine—KCND2—telencephalon—epilepsy syndrome	0.000178	0.0084	CbGeAlD
Imipramine—KCND3—brainstem—epilepsy syndrome	0.000175	0.00825	CbGeAlD
Imipramine—KCND3—forebrain—epilepsy syndrome	0.000169	0.00796	CbGeAlD
Imipramine—HTR1A—ganglion—epilepsy syndrome	0.000167	0.00787	CbGeAlD
Imipramine—SLC6A2—ganglion—epilepsy syndrome	0.000166	0.00781	CbGeAlD
Imipramine—HTR2A—telencephalic ventricle—epilepsy syndrome	0.00016	0.00754	CbGeAlD
Imipramine—HTR7—ganglion—epilepsy syndrome	0.00016	0.00752	CbGeAlD
Imipramine—SLC6A3—hindbrain—epilepsy syndrome	0.000156	0.00734	CbGeAlD
Imipramine—KCND3—telencephalon—epilepsy syndrome	0.000156	0.00732	CbGeAlD
Imipramine—DRD2—ganglion—epilepsy syndrome	0.000151	0.00711	CbGeAlD
Imipramine—HTR6—forebrain—epilepsy syndrome	0.000144	0.00679	CbGeAlD
Imipramine—SLC6A4—hindbrain—epilepsy syndrome	0.000143	0.00672	CbGeAlD
Imipramine—KCND2—medulla oblongata—epilepsy syndrome	0.00014	0.0066	CbGeAlD
Imipramine—HTR6—telencephalon—epilepsy syndrome	0.000133	0.00624	CbGeAlD
Imipramine—KCND2—midbrain—epilepsy syndrome	0.000128	0.00603	CbGeAlD
Imipramine—HTR1A—hindbrain—epilepsy syndrome	0.000127	0.00597	CbGeAlD
Imipramine—KCND2—spinal cord—epilepsy syndrome	0.000125	0.00589	CbGeAlD
Imipramine—HTR7—hindbrain—epilepsy syndrome	0.000121	0.00571	CbGeAlD
Imipramine—ADRA1A—hindbrain—epilepsy syndrome	0.000117	0.0055	CbGeAlD
Imipramine—DRD2—hindbrain—epilepsy syndrome	0.000115	0.00539	CbGeAlD
Imipramine—ADRA1D—forebrain—epilepsy syndrome	0.000113	0.0053	CbGeAlD
Imipramine—KCND3—midbrain—epilepsy syndrome	0.000112	0.00526	CbGeAlD
Imipramine—KCND2—head—epilepsy syndrome	0.000111	0.00523	CbGeAlD
Imipramine—KCND2—nervous system—epilepsy syndrome	0.000105	0.00496	CbGeAlD
Imipramine—ADRA1D—telencephalon—epilepsy syndrome	0.000104	0.00487	CbGeAlD
Imipramine—KCND2—central nervous system—epilepsy syndrome	0.000101	0.00477	CbGeAlD
Imipramine—HTR2A—ganglion—epilepsy syndrome	9.96e-05	0.00469	CbGeAlD
Imipramine—KCND2—cerebellum—epilepsy syndrome	9.91e-05	0.00467	CbGeAlD
Imipramine—KCND3—head—epilepsy syndrome	9.68e-05	0.00456	CbGeAlD
Imipramine—CHRM4—head—epilepsy syndrome	9.23e-05	0.00434	CbGeAlD
Imipramine—KCND3—nervous system—epilepsy syndrome	9.18e-05	0.00432	CbGeAlD
Imipramine—SLC6A3—brainstem—epilepsy syndrome	8.93e-05	0.00421	CbGeAlD
Imipramine—KCND3—central nervous system—epilepsy syndrome	8.84e-05	0.00416	CbGeAlD
Imipramine—CHRM4—nervous system—epilepsy syndrome	8.75e-05	0.00412	CbGeAlD
Imipramine—CHRM2—forebrain—epilepsy syndrome	8.64e-05	0.00407	CbGeAlD
Imipramine—KCND3—cerebellum—epilepsy syndrome	8.64e-05	0.00407	CbGeAlD
Imipramine—HTR2C—brainstem—epilepsy syndrome	8.63e-05	0.00406	CbGeAlD
Imipramine—SLC6A3—forebrain—epilepsy syndrome	8.62e-05	0.00406	CbGeAlD
Imipramine—SLC22A1—forebrain—epilepsy syndrome	8.49e-05	0.004	CbGeAlD
Imipramine—CHRM4—central nervous system—epilepsy syndrome	8.42e-05	0.00397	CbGeAlD
Imipramine—HTR2C—forebrain—epilepsy syndrome	8.33e-05	0.00392	CbGeAlD
Imipramine—HTR6—head—epilepsy syndrome	8.26e-05	0.00389	CbGeAlD
Imipramine—SLC6A4—brainstem—epilepsy syndrome	8.18e-05	0.00385	CbGeAlD
Imipramine—KCND2—brain—epilepsy syndrome	8.05e-05	0.00379	CbGeAlD
Imipramine—CHRM2—telencephalon—epilepsy syndrome	7.95e-05	0.00374	CbGeAlD
Imipramine—SLC6A3—telencephalon—epilepsy syndrome	7.93e-05	0.00373	CbGeAlD
Imipramine—SLC6A4—forebrain—epilepsy syndrome	7.9e-05	0.00372	CbGeAlD
Imipramine—CHRM1—forebrain—epilepsy syndrome	7.87e-05	0.0037	CbGeAlD
Imipramine—Olopatadine—S100B—epilepsy syndrome	7.83e-05	0.0515	CrCbGaD
Imipramine—HTR6—nervous system—epilepsy syndrome	7.83e-05	0.00369	CbGeAlD
Imipramine—SLC22A1—telencephalon—epilepsy syndrome	7.81e-05	0.00368	CbGeAlD
Imipramine—HTR2C—telencephalon—epilepsy syndrome	7.66e-05	0.00361	CbGeAlD
Imipramine—HTR2A—hindbrain—epilepsy syndrome	7.56e-05	0.00356	CbGeAlD
Imipramine—HTR6—central nervous system—epilepsy syndrome	7.54e-05	0.00355	CbGeAlD
Imipramine—HTR1A—brainstem—epilepsy syndrome	7.27e-05	0.00342	CbGeAlD
Imipramine—SLC6A4—telencephalon—epilepsy syndrome	7.26e-05	0.00342	CbGeAlD
Imipramine—CHRM1—telencephalon—epilepsy syndrome	7.24e-05	0.00341	CbGeAlD
Imipramine—CHRM5—head—epilepsy syndrome	7.21e-05	0.0034	CbGeAlD
Imipramine—SLC6A2—brainstem—epilepsy syndrome	7.21e-05	0.00339	CbGeAlD
Imipramine—CHRM3—forebrain—epilepsy syndrome	7.04e-05	0.00332	CbGeAlD
Imipramine—KCND3—brain—epilepsy syndrome	7.02e-05	0.0033	CbGeAlD
Imipramine—HTR1A—forebrain—epilepsy syndrome	7.01e-05	0.0033	CbGeAlD
Imipramine—SLC6A2—forebrain—epilepsy syndrome	6.95e-05	0.00327	CbGeAlD
Imipramine—HTR7—brainstem—epilepsy syndrome	6.94e-05	0.00327	CbGeAlD
Imipramine—CYP2D6—hindbrain—epilepsy syndrome	6.88e-05	0.00324	CbGeAlD
Imipramine—CHRM5—nervous system—epilepsy syndrome	6.84e-05	0.00322	CbGeAlD
Imipramine—HTR7—forebrain—epilepsy syndrome	6.7e-05	0.00316	CbGeAlD
Imipramine—ADRA1A—brainstem—epilepsy syndrome	6.7e-05	0.00315	CbGeAlD
Imipramine—CHRM4—brain—epilepsy syndrome	6.69e-05	0.00315	CbGeAlD
Imipramine—ADRA1B—head—epilepsy syndrome	6.59e-05	0.0031	CbGeAlD
Imipramine—CHRM5—central nervous system—epilepsy syndrome	6.58e-05	0.0031	CbGeAlD
Imipramine—DRD2—brainstem—epilepsy syndrome	6.57e-05	0.00309	CbGeAlD
Imipramine—CHRM3—telencephalon—epilepsy syndrome	6.47e-05	0.00305	CbGeAlD
Imipramine—ADRA1A—forebrain—epilepsy syndrome	6.46e-05	0.00304	CbGeAlD
Imipramine—HTR1A—telencephalon—epilepsy syndrome	6.45e-05	0.00304	CbGeAlD
Imipramine—ADRA1D—head—epilepsy syndrome	6.45e-05	0.00303	CbGeAlD
Imipramine—SLC6A2—telencephalon—epilepsy syndrome	6.39e-05	0.00301	CbGeAlD
Imipramine—DRD2—forebrain—epilepsy syndrome	6.34e-05	0.00298	CbGeAlD
Imipramine—ADRA1B—nervous system—epilepsy syndrome	6.25e-05	0.00294	CbGeAlD
Imipramine—KCNH2—forebrain—epilepsy syndrome	6.24e-05	0.00294	CbGeAlD
Imipramine—HTR7—telencephalon—epilepsy syndrome	6.16e-05	0.0029	CbGeAlD
Imipramine—ADRA1D—nervous system—epilepsy syndrome	6.11e-05	0.00288	CbGeAlD
Imipramine—HTR2C—medulla oblongata—epilepsy syndrome	6.02e-05	0.00283	CbGeAlD
Imipramine—ADRA1B—central nervous system—epilepsy syndrome	6.01e-05	0.00283	CbGeAlD
Imipramine—HTR6—brain—epilepsy syndrome	5.98e-05	0.00282	CbGeAlD
Imipramine—ORM1—spinal cord—epilepsy syndrome	5.97e-05	0.00281	CbGeAlD
Imipramine—ADRA1A—telencephalon—epilepsy syndrome	5.94e-05	0.0028	CbGeAlD
Imipramine—ADRA1D—central nervous system—epilepsy syndrome	5.88e-05	0.00277	CbGeAlD
Imipramine—DRD2—telencephalon—epilepsy syndrome	5.83e-05	0.00274	CbGeAlD
Imipramine—SLC22A4—spinal cord—epilepsy syndrome	5.75e-05	0.00271	CbGeAlD
Imipramine—KCNH2—telencephalon—epilepsy syndrome	5.74e-05	0.0027	CbGeAlD
Imipramine—SLC6A3—midbrain—epilepsy syndrome	5.69e-05	0.00268	CbGeAlD
Imipramine—SLC6A3—spinal cord—epilepsy syndrome	5.55e-05	0.00261	CbGeAlD
Imipramine—HTR2C—midbrain—epilepsy syndrome	5.5e-05	0.00259	CbGeAlD
Imipramine—HTR2C—spinal cord—epilepsy syndrome	5.37e-05	0.00253	CbGeAlD
Imipramine—CHRM5—brain—epilepsy syndrome	5.23e-05	0.00246	CbGeAlD
Imipramine—SLC6A4—midbrain—epilepsy syndrome	5.22e-05	0.00246	CbGeAlD
Imipramine—SLC6A4—spinal cord—epilepsy syndrome	5.09e-05	0.0024	CbGeAlD
Imipramine—ORM1—nervous system—epilepsy syndrome	5.03e-05	0.00237	CbGeAlD
Imipramine—SLC6A2—medulla oblongata—epilepsy syndrome	5.02e-05	0.00237	CbGeAlD
Imipramine—HRH1—forebrain—epilepsy syndrome	5e-05	0.00236	CbGeAlD
Imipramine—CHRM2—head—epilepsy syndrome	4.95e-05	0.00233	CbGeAlD
Imipramine—SLC6A3—head—epilepsy syndrome	4.94e-05	0.00232	CbGeAlD
Imipramine—SLC22A1—head—epilepsy syndrome	4.86e-05	0.00229	CbGeAlD
Imipramine—ORM1—central nervous system—epilepsy syndrome	4.85e-05	0.00228	CbGeAlD
Imipramine—HTR7—medulla oblongata—epilepsy syndrome	4.84e-05	0.00228	CbGeAlD
Imipramine—ADRA1B—brain—epilepsy syndrome	4.77e-05	0.00225	CbGeAlD
Imipramine—HTR2C—head—epilepsy syndrome	4.77e-05	0.00225	CbGeAlD
Imipramine—CHRM2—nervous system—epilepsy syndrome	4.69e-05	0.00221	CbGeAlD
Imipramine—SLC6A3—nervous system—epilepsy syndrome	4.68e-05	0.0022	CbGeAlD
Imipramine—ADRA1D—brain—epilepsy syndrome	4.67e-05	0.0022	CbGeAlD
Imipramine—SLC22A3—head—epilepsy syndrome	4.65e-05	0.00219	CbGeAlD
Imipramine—HTR1A—midbrain—epilepsy syndrome	4.63e-05	0.00218	CbGeAlD
Imipramine—SLC22A1—nervous system—epilepsy syndrome	4.61e-05	0.00217	CbGeAlD
Imipramine—HRH1—telencephalon—epilepsy syndrome	4.6e-05	0.00217	CbGeAlD
Imipramine—SLC22A4—cerebellum—epilepsy syndrome	4.56e-05	0.00214	CbGeAlD
Imipramine—HTR2C—nervous system—epilepsy syndrome	4.52e-05	0.00213	CbGeAlD
Imipramine—SLC6A4—head—epilepsy syndrome	4.52e-05	0.00213	CbGeAlD
Imipramine—HTR1A—spinal cord—epilepsy syndrome	4.52e-05	0.00213	CbGeAlD
Imipramine—CHRM2—central nervous system—epilepsy syndrome	4.52e-05	0.00213	CbGeAlD
Imipramine—KCNH2—medulla oblongata—epilepsy syndrome	4.51e-05	0.00212	CbGeAlD
Imipramine—CHRM1—head—epilepsy syndrome	4.51e-05	0.00212	CbGeAlD
Imipramine—SLC6A3—central nervous system—epilepsy syndrome	4.51e-05	0.00212	CbGeAlD
Imipramine—SLC22A1—central nervous system—epilepsy syndrome	4.44e-05	0.00209	CbGeAlD
Imipramine—HTR7—midbrain—epilepsy syndrome	4.43e-05	0.00208	CbGeAlD
Imipramine—CYP2E1—telencephalon—epilepsy syndrome	4.42e-05	0.00208	CbGeAlD
Imipramine—SLC22A3—nervous system—epilepsy syndrome	4.41e-05	0.00207	CbGeAlD
Imipramine—SLC6A3—cerebellum—epilepsy syndrome	4.4e-05	0.00207	CbGeAlD
Imipramine—HTR2C—central nervous system—epilepsy syndrome	4.35e-05	0.00205	CbGeAlD
Imipramine—HTR2A—brainstem—epilepsy syndrome	4.33e-05	0.00204	CbGeAlD
Imipramine—HTR7—spinal cord—epilepsy syndrome	4.32e-05	0.00203	CbGeAlD
Imipramine—SLC6A4—nervous system—epilepsy syndrome	4.29e-05	0.00202	CbGeAlD
Imipramine—CHRM1—nervous system—epilepsy syndrome	4.27e-05	0.00201	CbGeAlD
Imipramine—SLC22A3—central nervous system—epilepsy syndrome	4.24e-05	0.002	CbGeAlD
Imipramine—DRD2—midbrain—epilepsy syndrome	4.18e-05	0.00197	CbGeAlD
Imipramine—HTR2A—forebrain—epilepsy syndrome	4.18e-05	0.00197	CbGeAlD
Imipramine—SLC6A4—central nervous system—epilepsy syndrome	4.13e-05	0.00194	CbGeAlD
Imipramine—KCNH2—midbrain—epilepsy syndrome	4.12e-05	0.00194	CbGeAlD
Imipramine—CHRM1—central nervous system—epilepsy syndrome	4.11e-05	0.00194	CbGeAlD
Imipramine—CHRM3—head—epilepsy syndrome	4.03e-05	0.0019	CbGeAlD
Imipramine—KCNH2—spinal cord—epilepsy syndrome	4.02e-05	0.00189	CbGeAlD
Imipramine—HTR1A—head—epilepsy syndrome	4.02e-05	0.00189	CbGeAlD
Imipramine—SLC6A2—head—epilepsy syndrome	3.98e-05	0.00187	CbGeAlD
Imipramine—CYP2D6—brainstem—epilepsy syndrome	3.95e-05	0.00186	CbGeAlD
Imipramine—HTR2A—telencephalon—epilepsy syndrome	3.84e-05	0.00181	CbGeAlD
Imipramine—HTR7—head—epilepsy syndrome	3.84e-05	0.00181	CbGeAlD
Imipramine—CHRM3—nervous system—epilepsy syndrome	3.82e-05	0.0018	CbGeAlD
Imipramine—CYP2D6—forebrain—epilepsy syndrome	3.81e-05	0.00179	CbGeAlD
Imipramine—HTR1A—nervous system—epilepsy syndrome	3.81e-05	0.00179	CbGeAlD
Imipramine—Carbamazepine—SCN9A—epilepsy syndrome	3.8e-05	0.025	CrCbGaD
Imipramine—SLC6A2—nervous system—epilepsy syndrome	3.78e-05	0.00178	CbGeAlD
Imipramine—ADRA1A—head—epilepsy syndrome	3.7e-05	0.00174	CbGeAlD
Imipramine—SLC22A4—brain—epilepsy syndrome	3.7e-05	0.00174	CbGeAlD
Imipramine—CHRM3—central nervous system—epilepsy syndrome	3.68e-05	0.00173	CbGeAlD
Imipramine—HTR1A—central nervous system—epilepsy syndrome	3.67e-05	0.00173	CbGeAlD
Imipramine—HTR7—nervous system—epilepsy syndrome	3.64e-05	0.00171	CbGeAlD
Imipramine—SLC6A2—central nervous system—epilepsy syndrome	3.63e-05	0.00171	CbGeAlD
Imipramine—DRD2—head—epilepsy syndrome	3.63e-05	0.00171	CbGeAlD
Imipramine—CHRM2—brain—epilepsy syndrome	3.59e-05	0.00169	CbGeAlD
Imipramine—HTR1A—cerebellum—epilepsy syndrome	3.58e-05	0.00169	CbGeAlD
Imipramine—SLC6A3—brain—epilepsy syndrome	3.58e-05	0.00168	CbGeAlD
Imipramine—KCNH2—head—epilepsy syndrome	3.58e-05	0.00168	CbGeAlD
Imipramine—Amitriptyline—KCND2—epilepsy syndrome	3.54e-05	0.0233	CrCbGaD
Imipramine—SLC22A1—brain—epilepsy syndrome	3.52e-05	0.00166	CbGeAlD
Imipramine—ADRA1A—nervous system—epilepsy syndrome	3.51e-05	0.00165	CbGeAlD
Imipramine—HTR7—central nervous system—epilepsy syndrome	3.5e-05	0.00165	CbGeAlD
Imipramine—CYP2D6—telencephalon—epilepsy syndrome	3.5e-05	0.00165	CbGeAlD
Imipramine—Carbamazepine—SCN4A—epilepsy syndrome	3.49e-05	0.0229	CrCbGaD
Imipramine—CYP2E1—medulla oblongata—epilepsy syndrome	3.47e-05	0.00164	CbGeAlD
Imipramine—HTR2C—brain—epilepsy syndrome	3.46e-05	0.00163	CbGeAlD
Imipramine—DRD2—nervous system—epilepsy syndrome	3.44e-05	0.00162	CbGeAlD
Imipramine—HTR7—cerebellum—epilepsy syndrome	3.42e-05	0.00161	CbGeAlD
Imipramine—KCNH2—nervous system—epilepsy syndrome	3.39e-05	0.0016	CbGeAlD
Imipramine—ADRA1A—central nervous system—epilepsy syndrome	3.38e-05	0.00159	CbGeAlD
Imipramine—SLC22A3—brain—epilepsy syndrome	3.37e-05	0.00159	CbGeAlD
Imipramine—DRD2—central nervous system—epilepsy syndrome	3.31e-05	0.00156	CbGeAlD
Imipramine—ADRA1A—cerebellum—epilepsy syndrome	3.3e-05	0.00156	CbGeAlD
Imipramine—Amitriptyline—KCNQ3—epilepsy syndrome	3.29e-05	0.0216	CrCbGaD
Imipramine—Amitriptyline—KCNQ2—epilepsy syndrome	3.29e-05	0.0216	CrCbGaD
Imipramine—SLC6A4—brain—epilepsy syndrome	3.28e-05	0.00154	CbGeAlD
Imipramine—CHRM1—brain—epilepsy syndrome	3.26e-05	0.00154	CbGeAlD
Imipramine—KCNH2—central nervous system—epilepsy syndrome	3.26e-05	0.00154	CbGeAlD
Imipramine—DRD2—cerebellum—epilepsy syndrome	3.24e-05	0.00152	CbGeAlD
Imipramine—Doxylamine—CHRM1—epilepsy syndrome	3.23e-05	0.0212	CrCbGaD
Imipramine—KCNH2—cerebellum—epilepsy syndrome	3.19e-05	0.0015	CbGeAlD
Imipramine—CYP2E1—spinal cord—epilepsy syndrome	3.1e-05	0.00146	CbGeAlD
Imipramine—HTR2A—medulla oblongata—epilepsy syndrome	3.02e-05	0.00142	CbGeAlD
Imipramine—CYP2B6—head—epilepsy syndrome	2.93e-05	0.00138	CbGeAlD
Imipramine—CHRM3—brain—epilepsy syndrome	2.92e-05	0.00138	CbGeAlD
Imipramine—HTR1A—brain—epilepsy syndrome	2.91e-05	0.00137	CbGeAlD
Imipramine—SLC6A2—brain—epilepsy syndrome	2.89e-05	0.00136	CbGeAlD
Imipramine—HRH1—head—epilepsy syndrome	2.87e-05	0.00135	CbGeAlD
Imipramine—Amitriptyline—NTRK2—epilepsy syndrome	2.8e-05	0.0184	CrCbGaD
Imipramine—CYP2B6—nervous system—epilepsy syndrome	2.78e-05	0.00131	CbGeAlD
Imipramine—HTR7—brain—epilepsy syndrome	2.78e-05	0.00131	CbGeAlD
Imipramine—HTR2A—midbrain—epilepsy syndrome	2.76e-05	0.0013	CbGeAlD
Imipramine—CYP2E1—head—epilepsy syndrome	2.75e-05	0.0013	CbGeAlD
Imipramine—ABCB1—forebrain—epilepsy syndrome	2.74e-05	0.00129	CbGeAlD
Imipramine—Orphenadrine—SCN9A—epilepsy syndrome	2.74e-05	0.018	CrCbGaD
Imipramine—HRH1—nervous system—epilepsy syndrome	2.72e-05	0.00128	CbGeAlD
Imipramine—HTR2A—spinal cord—epilepsy syndrome	2.69e-05	0.00127	CbGeAlD
Imipramine—ADRA1A—brain—epilepsy syndrome	2.68e-05	0.00126	CbGeAlD
Imipramine—CYP2B6—central nervous system—epilepsy syndrome	2.68e-05	0.00126	CbGeAlD
Imipramine—DRD2—brain—epilepsy syndrome	2.63e-05	0.00124	CbGeAlD
Imipramine—HRH1—central nervous system—epilepsy syndrome	2.62e-05	0.00123	CbGeAlD
Imipramine—CYP2E1—nervous system—epilepsy syndrome	2.61e-05	0.00123	CbGeAlD
Imipramine—KCNH2—brain—epilepsy syndrome	2.59e-05	0.00122	CbGeAlD
Imipramine—ABCB1—telencephalon—epilepsy syndrome	2.52e-05	0.00119	CbGeAlD
Imipramine—Orphenadrine—SCN4A—epilepsy syndrome	2.51e-05	0.0165	CrCbGaD
Imipramine—CYP2E1—central nervous system—epilepsy syndrome	2.51e-05	0.00118	CbGeAlD
Imipramine—CYP2E1—cerebellum—epilepsy syndrome	2.46e-05	0.00116	CbGeAlD
Imipramine—HTR2A—head—epilepsy syndrome	2.39e-05	0.00113	CbGeAlD
Imipramine—Maprotiline—CHRM3—epilepsy syndrome	2.34e-05	0.0154	CrCbGaD
Imipramine—Ethopropazine—CHRM1—epilepsy syndrome	2.33e-05	0.0153	CrCbGaD
Imipramine—Dimetindene—CHRM2—epilepsy syndrome	2.3e-05	0.0151	CrCbGaD
Imipramine—HTR2A—nervous system—epilepsy syndrome	2.27e-05	0.00107	CbGeAlD
Imipramine—Cyamemazine—CHRM2—epilepsy syndrome	2.24e-05	0.0147	CrCbGaD
Imipramine—HTR2A—central nervous system—epilepsy syndrome	2.18e-05	0.00103	CbGeAlD
Imipramine—CYP2D6—head—epilepsy syndrome	2.18e-05	0.00103	CbGeAlD
Imipramine—Maprotiline—CHRM1—epilepsy syndrome	2.18e-05	0.0143	CrCbGaD
Imipramine—HTR2A—cerebellum—epilepsy syndrome	2.14e-05	0.00101	CbGeAlD
Imipramine—CYP2B6—brain—epilepsy syndrome	2.13e-05	0.001	CbGeAlD
Imipramine—CYP3A4—nervous system—epilepsy syndrome	2.1e-05	0.000989	CbGeAlD
Imipramine—HRH1—brain—epilepsy syndrome	2.08e-05	0.000978	CbGeAlD
Imipramine—CYP2D6—nervous system—epilepsy syndrome	2.07e-05	0.000973	CbGeAlD
Imipramine—Epinastine—HTR7—epilepsy syndrome	2.06e-05	0.0135	CrCbGaD
Imipramine—CYP3A4—central nervous system—epilepsy syndrome	2.02e-05	0.000952	CbGeAlD
Imipramine—CYP2E1—brain—epilepsy syndrome	2e-05	0.00094	CbGeAlD
Imipramine—CYP2D6—central nervous system—epilepsy syndrome	1.99e-05	0.000937	CbGeAlD
Imipramine—ABCB1—medulla oblongata—epilepsy syndrome	1.98e-05	0.000932	CbGeAlD
Imipramine—Mequitazine—CHRM2—epilepsy syndrome	1.95e-05	0.0128	CrCbGaD
Imipramine—CYP2D6—cerebellum—epilepsy syndrome	1.95e-05	0.000916	CbGeAlD
Imipramine—Triflupromazine—CHRM1—epilepsy syndrome	1.9e-05	0.0125	CrCbGaD
Imipramine—Ethopropazine—CHRM2—epilepsy syndrome	1.9e-05	0.0125	CrCbGaD
Imipramine—Orphenadrine—SCN1A—epilepsy syndrome	1.84e-05	0.0121	CrCbGaD
Imipramine—ABCB1—midbrain—epilepsy syndrome	1.81e-05	0.000852	CbGeAlD
Imipramine—Maprotiline—CHRM2—epilepsy syndrome	1.78e-05	0.0117	CrCbGaD
Imipramine—Maprotiline—HTR7—epilepsy syndrome	1.77e-05	0.0116	CrCbGaD
Imipramine—ABCB1—spinal cord—epilepsy syndrome	1.76e-05	0.000831	CbGeAlD
Imipramine—Epinastine—ADRA2A—epilepsy syndrome	1.76e-05	0.0116	CrCbGaD
Imipramine—HTR2A—brain—epilepsy syndrome	1.73e-05	0.000817	CbGeAlD
Imipramine—Ethopropazine—BCHE—epilepsy syndrome	1.58e-05	0.0104	CrCbGaD
Imipramine—CYP2D6—brain—epilepsy syndrome	1.58e-05	0.000744	CbGeAlD
Imipramine—ABCB1—head—epilepsy syndrome	1.57e-05	0.000738	CbGeAlD
Imipramine—Triflupromazine—CHRM2—epilepsy syndrome	1.56e-05	0.0102	CrCbGaD
Imipramine—ABCB1—nervous system—epilepsy syndrome	1.49e-05	0.0007	CbGeAlD
Imipramine—Nervous system disorder—Valproic Acid—epilepsy syndrome	1.43e-05	0.000263	CcSEcCtD
Imipramine—ABCB1—central nervous system—epilepsy syndrome	1.43e-05	0.000674	CbGeAlD
Imipramine—Thrombocytopenia—Valproic Acid—epilepsy syndrome	1.43e-05	0.000263	CcSEcCtD
Imipramine—Palpitations—Pregabalin—epilepsy syndrome	1.43e-05	0.000263	CcSEcCtD
Imipramine—Asthenia—Phenytoin—epilepsy syndrome	1.43e-05	0.000263	CcSEcCtD
Imipramine—Nausea—Midazolam—epilepsy syndrome	1.43e-05	0.000262	CcSEcCtD
Imipramine—Hypoaesthesia—Topiramate—epilepsy syndrome	1.43e-05	0.000262	CcSEcCtD
Imipramine—Hallucination—Topiramate—epilepsy syndrome	1.43e-05	0.000262	CcSEcCtD
Imipramine—Tachycardia—Valproic Acid—epilepsy syndrome	1.43e-05	0.000262	CcSEcCtD
Imipramine—Diarrhoea—Zonisamide—epilepsy syndrome	1.43e-05	0.000262	CcSEcCtD
Imipramine—Loss of consciousness—Pregabalin—epilepsy syndrome	1.42e-05	0.000261	CcSEcCtD
Imipramine—Asthenia—Oxcarbazepine—epilepsy syndrome	1.42e-05	0.000261	CcSEcCtD
Imipramine—Pruritus—Clonazepam—epilepsy syndrome	1.42e-05	0.000261	CcSEcCtD
Imipramine—Vomiting—Vigabatrin—epilepsy syndrome	1.42e-05	0.000261	CcSEcCtD
Imipramine—Skin disorder—Valproic Acid—epilepsy syndrome	1.42e-05	0.000261	CcSEcCtD
Imipramine—Urinary tract disorder—Topiramate—epilepsy syndrome	1.42e-05	0.00026	CcSEcCtD
Imipramine—Hyperhidrosis—Valproic Acid—epilepsy syndrome	1.41e-05	0.000259	CcSEcCtD
Imipramine—Pruritus—Phenytoin—epilepsy syndrome	1.41e-05	0.000259	CcSEcCtD
Imipramine—Nausea—Levetiracetam—epilepsy syndrome	1.41e-05	0.000259	CcSEcCtD
Imipramine—Rash—Vigabatrin—epilepsy syndrome	1.41e-05	0.000258	CcSEcCtD
Imipramine—Dizziness—Felbamate—epilepsy syndrome	1.41e-05	0.000258	CcSEcCtD
Imipramine—Dermatitis—Vigabatrin—epilepsy syndrome	1.41e-05	0.000258	CcSEcCtD
Imipramine—Urethral disorder—Topiramate—epilepsy syndrome	1.41e-05	0.000258	CcSEcCtD
Imipramine—Nortriptyline—CHRM3—epilepsy syndrome	1.4e-05	0.00923	CrCbGaD
Imipramine—Pruritus—Oxcarbazepine—epilepsy syndrome	1.4e-05	0.000258	CcSEcCtD
Imipramine—Convulsion—Pregabalin—epilepsy syndrome	1.4e-05	0.000258	CcSEcCtD
Imipramine—Vision blurred—Gabapentin—epilepsy syndrome	1.4e-05	0.000257	CcSEcCtD
Imipramine—ABCB1—cerebellum—epilepsy syndrome	1.4e-05	0.000659	CbGeAlD
Imipramine—Headache—Vigabatrin—epilepsy syndrome	1.4e-05	0.000257	CcSEcCtD
Imipramine—Hypertension—Pregabalin—epilepsy syndrome	1.4e-05	0.000257	CcSEcCtD
Imipramine—Vomiting—Diazepam—epilepsy syndrome	1.4e-05	0.000257	CcSEcCtD
Imipramine—Anorexia—Valproic Acid—epilepsy syndrome	1.39e-05	0.000256	CcSEcCtD
Imipramine—Tremor—Gabapentin—epilepsy syndrome	1.39e-05	0.000255	CcSEcCtD
Imipramine—Rash—Diazepam—epilepsy syndrome	1.39e-05	0.000254	CcSEcCtD
Imipramine—Dermatitis—Diazepam—epilepsy syndrome	1.39e-05	0.000254	CcSEcCtD
Imipramine—Ill-defined disorder—Gabapentin—epilepsy syndrome	1.38e-05	0.000253	CcSEcCtD
Imipramine—Dizziness—Zonisamide—epilepsy syndrome	1.38e-05	0.000253	CcSEcCtD
Imipramine—Headache—Diazepam—epilepsy syndrome	1.38e-05	0.000253	CcSEcCtD
Imipramine—Anxiety—Pregabalin—epilepsy syndrome	1.37e-05	0.000252	CcSEcCtD
Imipramine—Diarrhoea—Clonazepam—epilepsy syndrome	1.37e-05	0.000252	CcSEcCtD
Imipramine—Unspecified disorder of skin and subcutaneous tissue—Pregabalin—epilepsy syndrome	1.37e-05	0.000251	CcSEcCtD
Imipramine—Asthenia—Carbamazepine—epilepsy syndrome	1.37e-05	0.000251	CcSEcCtD
Imipramine—Agitation—Gabapentin—epilepsy syndrome	1.36e-05	0.00025	CcSEcCtD
Imipramine—Diarrhoea—Phenytoin—epilepsy syndrome	1.36e-05	0.00025	CcSEcCtD
Imipramine—Discomfort—Pregabalin—epilepsy syndrome	1.36e-05	0.00025	CcSEcCtD
Imipramine—Nausea—Fosphenytoin—epilepsy syndrome	1.36e-05	0.00025	CcSEcCtD
Imipramine—Diarrhoea—Oxcarbazepine—epilepsy syndrome	1.36e-05	0.000249	CcSEcCtD
Imipramine—Vomiting—Felbamate—epilepsy syndrome	1.35e-05	0.000248	CcSEcCtD
Imipramine—Dry mouth—Pregabalin—epilepsy syndrome	1.35e-05	0.000247	CcSEcCtD
Imipramine—Pruritus—Carbamazepine—epilepsy syndrome	1.35e-05	0.000247	CcSEcCtD
Imipramine—Rash—Felbamate—epilepsy syndrome	1.34e-05	0.000246	CcSEcCtD
Imipramine—Eye disorder—Topiramate—epilepsy syndrome	1.34e-05	0.000246	CcSEcCtD
Imipramine—Dermatitis—Felbamate—epilepsy syndrome	1.34e-05	0.000246	CcSEcCtD
Imipramine—Malaise—Gabapentin—epilepsy syndrome	1.34e-05	0.000246	CcSEcCtD
Imipramine—Tinnitus—Topiramate—epilepsy syndrome	1.34e-05	0.000246	CcSEcCtD
Imipramine—Headache—Felbamate—epilepsy syndrome	1.33e-05	0.000245	CcSEcCtD
Imipramine—Confusional state—Pregabalin—epilepsy syndrome	1.33e-05	0.000245	CcSEcCtD
Imipramine—Flushing—Topiramate—epilepsy syndrome	1.33e-05	0.000244	CcSEcCtD
Imipramine—Cardiac disorder—Topiramate—epilepsy syndrome	1.33e-05	0.000244	CcSEcCtD
Imipramine—Syncope—Gabapentin—epilepsy syndrome	1.33e-05	0.000244	CcSEcCtD
Imipramine—Leukopenia—Gabapentin—epilepsy syndrome	1.33e-05	0.000244	CcSEcCtD
Imipramine—Dizziness—Clonazepam—epilepsy syndrome	1.33e-05	0.000244	CcSEcCtD
Imipramine—Nausea—Vigabatrin—epilepsy syndrome	1.33e-05	0.000243	CcSEcCtD
Imipramine—Vomiting—Zonisamide—epilepsy syndrome	1.32e-05	0.000243	CcSEcCtD
Imipramine—Prochlorperazine—CHRM2—epilepsy syndrome	1.32e-05	0.00869	CrCbGaD
Imipramine—Insomnia—Valproic Acid—epilepsy syndrome	1.32e-05	0.000243	CcSEcCtD
Imipramine—Oedema—Pregabalin—epilepsy syndrome	1.32e-05	0.000243	CcSEcCtD
Imipramine—Anaphylactic shock—Pregabalin—epilepsy syndrome	1.32e-05	0.000243	CcSEcCtD
Imipramine—Asthenia—Lamotrigine—epilepsy syndrome	1.32e-05	0.000242	CcSEcCtD
Imipramine—Dizziness—Phenytoin—epilepsy syndrome	1.32e-05	0.000242	CcSEcCtD
Imipramine—Rash—Zonisamide—epilepsy syndrome	1.31e-05	0.000241	CcSEcCtD
Imipramine—Infection—Pregabalin—epilepsy syndrome	1.31e-05	0.000241	CcSEcCtD
Imipramine—Paraesthesia—Valproic Acid—epilepsy syndrome	1.31e-05	0.000241	CcSEcCtD
Imipramine—Palpitations—Gabapentin—epilepsy syndrome	1.31e-05	0.000241	CcSEcCtD
Imipramine—Dermatitis—Zonisamide—epilepsy syndrome	1.31e-05	0.000241	CcSEcCtD
Imipramine—Dizziness—Oxcarbazepine—epilepsy syndrome	1.31e-05	0.000241	CcSEcCtD
Imipramine—Nortriptyline—CHRM1—epilepsy syndrome	1.31e-05	0.00861	CrCbGaD
Imipramine—Nausea—Diazepam—epilepsy syndrome	1.31e-05	0.00024	CcSEcCtD
Imipramine—Loss of consciousness—Gabapentin—epilepsy syndrome	1.31e-05	0.00024	CcSEcCtD
Imipramine—Headache—Zonisamide—epilepsy syndrome	1.3e-05	0.00024	CcSEcCtD
Imipramine—Diarrhoea—Carbamazepine—epilepsy syndrome	1.3e-05	0.000239	CcSEcCtD
Imipramine—Angiopathy—Topiramate—epilepsy syndrome	1.3e-05	0.000239	CcSEcCtD
Imipramine—Pruritus—Lamotrigine—epilepsy syndrome	1.3e-05	0.000239	CcSEcCtD
Imipramine—Shock—Pregabalin—epilepsy syndrome	1.3e-05	0.000239	CcSEcCtD
Imipramine—Somnolence—Valproic Acid—epilepsy syndrome	1.3e-05	0.000239	CcSEcCtD
Imipramine—Triflupromazine—BCHE—epilepsy syndrome	1.3e-05	0.00853	CrCbGaD
Imipramine—Immune system disorder—Topiramate—epilepsy syndrome	1.3e-05	0.000238	CcSEcCtD
Imipramine—Nervous system disorder—Pregabalin—epilepsy syndrome	1.3e-05	0.000238	CcSEcCtD
Imipramine—Thrombocytopenia—Pregabalin—epilepsy syndrome	1.29e-05	0.000238	CcSEcCtD
Imipramine—Mediastinal disorder—Topiramate—epilepsy syndrome	1.29e-05	0.000237	CcSEcCtD
Imipramine—Methotrimeprazine—CHRM3—epilepsy syndrome	1.29e-05	0.00849	CrCbGaD
Imipramine—Tachycardia—Pregabalin—epilepsy syndrome	1.29e-05	0.000237	CcSEcCtD
Imipramine—Dyspepsia—Valproic Acid—epilepsy syndrome	1.29e-05	0.000236	CcSEcCtD
Imipramine—Convulsion—Gabapentin—epilepsy syndrome	1.29e-05	0.000236	CcSEcCtD
Imipramine—Skin disorder—Pregabalin—epilepsy syndrome	1.28e-05	0.000236	CcSEcCtD
Imipramine—Hypertension—Gabapentin—epilepsy syndrome	1.28e-05	0.000235	CcSEcCtD
Imipramine—Hyperhidrosis—Pregabalin—epilepsy syndrome	1.28e-05	0.000235	CcSEcCtD
Imipramine—Vomiting—Clonazepam—epilepsy syndrome	1.28e-05	0.000234	CcSEcCtD
Imipramine—Promethazine—CHRM3—epilepsy syndrome	1.27e-05	0.00837	CrCbGaD
Imipramine—Decreased appetite—Valproic Acid—epilepsy syndrome	1.27e-05	0.000233	CcSEcCtD
Imipramine—Alopecia—Topiramate—epilepsy syndrome	1.27e-05	0.000233	CcSEcCtD
Imipramine—Vomiting—Phenytoin—epilepsy syndrome	1.27e-05	0.000233	CcSEcCtD
Imipramine—Rash—Clonazepam—epilepsy syndrome	1.27e-05	0.000232	CcSEcCtD
Imipramine—Dermatitis—Clonazepam—epilepsy syndrome	1.26e-05	0.000232	CcSEcCtD
Imipramine—Nausea—Felbamate—epilepsy syndrome	1.26e-05	0.000232	CcSEcCtD
Imipramine—Gastrointestinal disorder—Valproic Acid—epilepsy syndrome	1.26e-05	0.000232	CcSEcCtD
Imipramine—Vomiting—Oxcarbazepine—epilepsy syndrome	1.26e-05	0.000231	CcSEcCtD
Imipramine—Fatigue—Valproic Acid—epilepsy syndrome	1.26e-05	0.000231	CcSEcCtD
Imipramine—Anxiety—Gabapentin—epilepsy syndrome	1.26e-05	0.000231	CcSEcCtD
Imipramine—Anorexia—Pregabalin—epilepsy syndrome	1.26e-05	0.000231	CcSEcCtD
Imipramine—Doxepin—CHRM3—epilepsy syndrome	1.26e-05	0.00828	CrCbGaD
Imipramine—Dizziness—Carbamazepine—epilepsy syndrome	1.26e-05	0.000231	CcSEcCtD
Imipramine—Diarrhoea—Lamotrigine—epilepsy syndrome	1.26e-05	0.000231	CcSEcCtD
Imipramine—Headache—Clonazepam—epilepsy syndrome	1.26e-05	0.000231	CcSEcCtD
Imipramine—Rash—Phenytoin—epilepsy syndrome	1.26e-05	0.000231	CcSEcCtD
Imipramine—Mental disorder—Topiramate—epilepsy syndrome	1.26e-05	0.000231	CcSEcCtD
Imipramine—Dermatitis—Phenytoin—epilepsy syndrome	1.26e-05	0.000231	CcSEcCtD
Imipramine—Unspecified disorder of skin and subcutaneous tissue—Gabapentin—epilepsy syndrome	1.26e-05	0.00023	CcSEcCtD
Imipramine—Rash—Oxcarbazepine—epilepsy syndrome	1.25e-05	0.00023	CcSEcCtD
Imipramine—Constipation—Valproic Acid—epilepsy syndrome	1.25e-05	0.000229	CcSEcCtD
Imipramine—Dermatitis—Oxcarbazepine—epilepsy syndrome	1.25e-05	0.000229	CcSEcCtD
Imipramine—Headache—Phenytoin—epilepsy syndrome	1.25e-05	0.000229	CcSEcCtD
Imipramine—Malnutrition—Topiramate—epilepsy syndrome	1.25e-05	0.000229	CcSEcCtD
Imipramine—Discomfort—Gabapentin—epilepsy syndrome	1.25e-05	0.000229	CcSEcCtD
Imipramine—Headache—Oxcarbazepine—epilepsy syndrome	1.24e-05	0.000228	CcSEcCtD
Imipramine—Nausea—Zonisamide—epilepsy syndrome	1.24e-05	0.000227	CcSEcCtD
Imipramine—Dry mouth—Gabapentin—epilepsy syndrome	1.24e-05	0.000227	CcSEcCtD
Imipramine—Tension—Topiramate—epilepsy syndrome	1.23e-05	0.000225	CcSEcCtD
Imipramine—Dysgeusia—Topiramate—epilepsy syndrome	1.22e-05	0.000225	CcSEcCtD
Imipramine—Confusional state—Gabapentin—epilepsy syndrome	1.22e-05	0.000224	CcSEcCtD
Imipramine—Dizziness—Lamotrigine—epilepsy syndrome	1.22e-05	0.000223	CcSEcCtD
Imipramine—Nervousness—Topiramate—epilepsy syndrome	1.21e-05	0.000223	CcSEcCtD
Imipramine—Oedema—Gabapentin—epilepsy syndrome	1.21e-05	0.000222	CcSEcCtD
Imipramine—Anaphylactic shock—Gabapentin—epilepsy syndrome	1.21e-05	0.000222	CcSEcCtD
Imipramine—Vomiting—Carbamazepine—epilepsy syndrome	1.21e-05	0.000222	CcSEcCtD
Imipramine—Methotrimeprazine—CHRM1—epilepsy syndrome	1.2e-05	0.00792	CrCbGaD
Imipramine—Feeling abnormal—Valproic Acid—epilepsy syndrome	1.2e-05	0.000221	CcSEcCtD
Imipramine—Infection—Gabapentin—epilepsy syndrome	1.2e-05	0.000221	CcSEcCtD
Imipramine—Rash—Carbamazepine—epilepsy syndrome	1.2e-05	0.00022	CcSEcCtD
Imipramine—Dermatitis—Carbamazepine—epilepsy syndrome	1.2e-05	0.00022	CcSEcCtD
Imipramine—Gastrointestinal pain—Valproic Acid—epilepsy syndrome	1.2e-05	0.000219	CcSEcCtD
Imipramine—Insomnia—Pregabalin—epilepsy syndrome	1.2e-05	0.000219	CcSEcCtD
Imipramine—Nausea—Clonazepam—epilepsy syndrome	1.19e-05	0.000219	CcSEcCtD
Imipramine—Headache—Carbamazepine—epilepsy syndrome	1.19e-05	0.000219	CcSEcCtD
Imipramine—Shock—Gabapentin—epilepsy syndrome	1.19e-05	0.000219	CcSEcCtD
Imipramine—Mianserin—HTR7—epilepsy syndrome	1.19e-05	0.00782	CrCbGaD
Imipramine—Nervous system disorder—Gabapentin—epilepsy syndrome	1.19e-05	0.000218	CcSEcCtD
Imipramine—Promethazine—CHRM1—epilepsy syndrome	1.19e-05	0.0078	CrCbGaD
Imipramine—Paraesthesia—Pregabalin—epilepsy syndrome	1.19e-05	0.000218	CcSEcCtD
Imipramine—Thrombocytopenia—Gabapentin—epilepsy syndrome	1.19e-05	0.000218	CcSEcCtD
Imipramine—Nausea—Phenytoin—epilepsy syndrome	1.18e-05	0.000217	CcSEcCtD
Imipramine—Tachycardia—Gabapentin—epilepsy syndrome	1.18e-05	0.000217	CcSEcCtD
Imipramine—Nausea—Oxcarbazepine—epilepsy syndrome	1.18e-05	0.000216	CcSEcCtD
Imipramine—Vision blurred—Topiramate—epilepsy syndrome	1.18e-05	0.000216	CcSEcCtD
Imipramine—Skin disorder—Gabapentin—epilepsy syndrome	1.18e-05	0.000216	CcSEcCtD
Imipramine—Oxcarbazepine—CYP2C19—epilepsy syndrome	1.18e-05	0.00773	CrCbGaD
Imipramine—Somnolence—Pregabalin—epilepsy syndrome	1.17e-05	0.000216	CcSEcCtD
Imipramine—Doxepin—CHRM1—epilepsy syndrome	1.17e-05	0.00772	CrCbGaD
Imipramine—Hyperhidrosis—Gabapentin—epilepsy syndrome	1.17e-05	0.000215	CcSEcCtD
Imipramine—Tremor—Topiramate—epilepsy syndrome	1.17e-05	0.000215	CcSEcCtD
Imipramine—Vomiting—Lamotrigine—epilepsy syndrome	1.17e-05	0.000215	CcSEcCtD
Imipramine—Urticaria—Valproic Acid—epilepsy syndrome	1.16e-05	0.000213	CcSEcCtD
Imipramine—Rash—Lamotrigine—epilepsy syndrome	1.16e-05	0.000213	CcSEcCtD
Imipramine—Ill-defined disorder—Topiramate—epilepsy syndrome	1.16e-05	0.000213	CcSEcCtD
Imipramine—Dermatitis—Lamotrigine—epilepsy syndrome	1.16e-05	0.000213	CcSEcCtD
Imipramine—Desipramine—CHRM3—epilepsy syndrome	1.16e-05	0.0076	CrCbGaD
Imipramine—Abdominal pain—Valproic Acid—epilepsy syndrome	1.16e-05	0.000212	CcSEcCtD
Imipramine—Body temperature increased—Valproic Acid—epilepsy syndrome	1.16e-05	0.000212	CcSEcCtD
Imipramine—Anorexia—Gabapentin—epilepsy syndrome	1.16e-05	0.000212	CcSEcCtD
Imipramine—Carbamazepine—ABCC2—epilepsy syndrome	1.15e-05	0.00758	CrCbGaD
Imipramine—Headache—Lamotrigine—epilepsy syndrome	1.15e-05	0.000212	CcSEcCtD
Imipramine—Decreased appetite—Pregabalin—epilepsy syndrome	1.15e-05	0.000211	CcSEcCtD
Imipramine—Agitation—Topiramate—epilepsy syndrome	1.15e-05	0.000211	CcSEcCtD
Imipramine—Tripelennamine—CYP2D6—epilepsy syndrome	1.15e-05	0.00754	CrCbGaD
Imipramine—Amitriptyline—OPRD1—epilepsy syndrome	1.15e-05	0.00753	CrCbGaD
Imipramine—Gastrointestinal disorder—Pregabalin—epilepsy syndrome	1.14e-05	0.000209	CcSEcCtD
Imipramine—Fatigue—Pregabalin—epilepsy syndrome	1.14e-05	0.000209	CcSEcCtD
Imipramine—ABCB1—brain—epilepsy syndrome	1.14e-05	0.000535	CbGeAlD
Imipramine—Nausea—Carbamazepine—epilepsy syndrome	1.13e-05	0.000208	CcSEcCtD
Imipramine—Constipation—Pregabalin—epilepsy syndrome	1.13e-05	0.000207	CcSEcCtD
Imipramine—Malaise—Topiramate—epilepsy syndrome	1.13e-05	0.000207	CcSEcCtD
Imipramine—Cyamemazine—HTR2A—epilepsy syndrome	1.12e-05	0.00737	CrCbGaD
Imipramine—Aprindine—CYP2D6—epilepsy syndrome	1.12e-05	0.00737	CrCbGaD
Imipramine—Syncope—Topiramate—epilepsy syndrome	1.12e-05	0.000206	CcSEcCtD
Imipramine—Promazine—CHRM3—epilepsy syndrome	1.12e-05	0.00736	CrCbGaD
Imipramine—Leukopenia—Topiramate—epilepsy syndrome	1.12e-05	0.000205	CcSEcCtD
Imipramine—Palpitations—Topiramate—epilepsy syndrome	1.1e-05	0.000203	CcSEcCtD
Imipramine—Loss of consciousness—Topiramate—epilepsy syndrome	1.1e-05	0.000202	CcSEcCtD
Imipramine—Insomnia—Gabapentin—epilepsy syndrome	1.1e-05	0.000201	CcSEcCtD
Imipramine—Nausea—Lamotrigine—epilepsy syndrome	1.09e-05	0.000201	CcSEcCtD
Imipramine—Feeling abnormal—Pregabalin—epilepsy syndrome	1.09e-05	0.0002	CcSEcCtD
Imipramine—Paraesthesia—Gabapentin—epilepsy syndrome	1.09e-05	0.0002	CcSEcCtD
Imipramine—Convulsion—Topiramate—epilepsy syndrome	1.08e-05	0.000199	CcSEcCtD
Imipramine—Gastrointestinal pain—Pregabalin—epilepsy syndrome	1.08e-05	0.000198	CcSEcCtD
Imipramine—Hypertension—Topiramate—epilepsy syndrome	1.08e-05	0.000198	CcSEcCtD
Imipramine—Desipramine—CHRM1—epilepsy syndrome	1.08e-05	0.00709	CrCbGaD
Imipramine—Somnolence—Gabapentin—epilepsy syndrome	1.08e-05	0.000198	CcSEcCtD
Imipramine—Nortriptyline—CHRM2—epilepsy syndrome	1.07e-05	0.00703	CrCbGaD
Imipramine—Dyspepsia—Gabapentin—epilepsy syndrome	1.07e-05	0.000196	CcSEcCtD
Imipramine—Anxiety—Topiramate—epilepsy syndrome	1.06e-05	0.000195	CcSEcCtD
Imipramine—Unspecified disorder of skin and subcutaneous tissue—Topiramate—epilepsy syndrome	1.06e-05	0.000194	CcSEcCtD
Imipramine—Decreased appetite—Gabapentin—epilepsy syndrome	1.05e-05	0.000193	CcSEcCtD
Imipramine—Discomfort—Topiramate—epilepsy syndrome	1.05e-05	0.000193	CcSEcCtD
Imipramine—Urticaria—Pregabalin—epilepsy syndrome	1.05e-05	0.000193	CcSEcCtD
Imipramine—Asthenia—Valproic Acid—epilepsy syndrome	1.05e-05	0.000193	CcSEcCtD
Imipramine—Gastrointestinal disorder—Gabapentin—epilepsy syndrome	1.05e-05	0.000192	CcSEcCtD
Imipramine—Fatigue—Gabapentin—epilepsy syndrome	1.04e-05	0.000192	CcSEcCtD
Imipramine—Abdominal pain—Pregabalin—epilepsy syndrome	1.04e-05	0.000192	CcSEcCtD
Imipramine—Body temperature increased—Pregabalin—epilepsy syndrome	1.04e-05	0.000192	CcSEcCtD
Imipramine—Promazine—CHRM1—epilepsy syndrome	1.04e-05	0.00686	CrCbGaD
Imipramine—Cyclobenzaprine—HTR2A—epilepsy syndrome	1.04e-05	0.00685	CrCbGaD
Imipramine—Dry mouth—Topiramate—epilepsy syndrome	1.04e-05	0.000191	CcSEcCtD
Imipramine—Constipation—Gabapentin—epilepsy syndrome	1.04e-05	0.00019	CcSEcCtD
Imipramine—Epinastine—HTR2A—epilepsy syndrome	1.03e-05	0.0068	CrCbGaD
Imipramine—Pruritus—Valproic Acid—epilepsy syndrome	1.03e-05	0.00019	CcSEcCtD
Imipramine—Confusional state—Topiramate—epilepsy syndrome	1.03e-05	0.000189	CcSEcCtD
Imipramine—Mianserin—ADRA2A—epilepsy syndrome	1.02e-05	0.00671	CrCbGaD
Imipramine—Oedema—Topiramate—epilepsy syndrome	1.02e-05	0.000187	CcSEcCtD
Imipramine—Infection—Topiramate—epilepsy syndrome	1.01e-05	0.000186	CcSEcCtD
Imipramine—Shock—Topiramate—epilepsy syndrome	1e-05	0.000184	CcSEcCtD
Imipramine—Diarrhoea—Valproic Acid—epilepsy syndrome	1e-05	0.000184	CcSEcCtD
Imipramine—Nervous system disorder—Topiramate—epilepsy syndrome	1e-05	0.000184	CcSEcCtD
Imipramine—Feeling abnormal—Gabapentin—epilepsy syndrome	9.99e-06	0.000183	CcSEcCtD
Imipramine—Thrombocytopenia—Topiramate—epilepsy syndrome	9.98e-06	0.000183	CcSEcCtD
Imipramine—Tachycardia—Topiramate—epilepsy syndrome	9.95e-06	0.000183	CcSEcCtD
Imipramine—Gastrointestinal pain—Gabapentin—epilepsy syndrome	9.91e-06	0.000182	CcSEcCtD
Imipramine—Skin disorder—Topiramate—epilepsy syndrome	9.9e-06	0.000182	CcSEcCtD
Imipramine—Diphenhydramine—CHRM2—epilepsy syndrome	9.88e-06	0.0065	CrCbGaD
Imipramine—Hyperhidrosis—Topiramate—epilepsy syndrome	9.86e-06	0.000181	CcSEcCtD
Imipramine—Chlorpromazine—CHRM3—epilepsy syndrome	9.85e-06	0.00648	CrCbGaD
Imipramine—Methotrimeprazine—CHRM2—epilepsy syndrome	9.84e-06	0.00647	CrCbGaD
Imipramine—Amitriptyline—CHRM3—epilepsy syndrome	9.74e-06	0.0064	CrCbGaD
Imipramine—Anorexia—Topiramate—epilepsy syndrome	9.72e-06	0.000178	CcSEcCtD
Imipramine—Promethazine—CHRM2—epilepsy syndrome	9.69e-06	0.00637	CrCbGaD
Imipramine—Dizziness—Valproic Acid—epilepsy syndrome	9.67e-06	0.000177	CcSEcCtD
Imipramine—Urticaria—Gabapentin—epilepsy syndrome	9.63e-06	0.000177	CcSEcCtD
Imipramine—Doxepin—CHRM2—epilepsy syndrome	9.59e-06	0.00631	CrCbGaD
Imipramine—Abdominal pain—Gabapentin—epilepsy syndrome	9.58e-06	0.000176	CcSEcCtD
Imipramine—Body temperature increased—Gabapentin—epilepsy syndrome	9.58e-06	0.000176	CcSEcCtD
Imipramine—Cyclobenzaprine—CYP2D6—epilepsy syndrome	9.53e-06	0.00626	CrCbGaD
Imipramine—Asthenia—Pregabalin—epilepsy syndrome	9.48e-06	0.000174	CcSEcCtD
Imipramine—Epinastine—CYP2D6—epilepsy syndrome	9.46e-06	0.00622	CrCbGaD
Imipramine—Pruritus—Pregabalin—epilepsy syndrome	9.35e-06	0.000172	CcSEcCtD
Imipramine—Orphenadrine—CHRM2—epilepsy syndrome	9.35e-06	0.00614	CrCbGaD
Imipramine—Clomipramine—ADRA2A—epilepsy syndrome	9.34e-06	0.00614	CrCbGaD
Imipramine—Vomiting—Valproic Acid—epilepsy syndrome	9.29e-06	0.000171	CcSEcCtD
Imipramine—Insomnia—Topiramate—epilepsy syndrome	9.22e-06	0.000169	CcSEcCtD
Imipramine—Rash—Valproic Acid—epilepsy syndrome	9.22e-06	0.000169	CcSEcCtD
Imipramine—Dermatitis—Valproic Acid—epilepsy syndrome	9.21e-06	0.000169	CcSEcCtD
Imipramine—Chlorpromazine—CHRM1—epilepsy syndrome	9.19e-06	0.00604	CrCbGaD
Imipramine—Headache—Valproic Acid—epilepsy syndrome	9.16e-06	0.000168	CcSEcCtD
Imipramine—Paraesthesia—Topiramate—epilepsy syndrome	9.15e-06	0.000168	CcSEcCtD
Imipramine—Amitriptyline—CHRM1—epilepsy syndrome	9.08e-06	0.00597	CrCbGaD
Imipramine—Somnolence—Topiramate—epilepsy syndrome	9.06e-06	0.000166	CcSEcCtD
Imipramine—Diarrhoea—Pregabalin—epilepsy syndrome	9.04e-06	0.000166	CcSEcCtD
Imipramine—Dyspepsia—Topiramate—epilepsy syndrome	8.97e-06	0.000165	CcSEcCtD
Imipramine—Maprotiline—HTR2A—epilepsy syndrome	8.9e-06	0.00585	CrCbGaD
Imipramine—Mequitazine—CYP2D6—epilepsy syndrome	8.9e-06	0.00585	CrCbGaD
Imipramine—Decreased appetite—Topiramate—epilepsy syndrome	8.86e-06	0.000163	CcSEcCtD
Imipramine—Gastrointestinal disorder—Topiramate—epilepsy syndrome	8.8e-06	0.000162	CcSEcCtD
Imipramine—Desipramine—CHRM2—epilepsy syndrome	8.8e-06	0.00579	CrCbGaD
Imipramine—Fatigue—Topiramate—epilepsy syndrome	8.79e-06	0.000161	CcSEcCtD
Imipramine—Amitriptyline—OPRM1—epilepsy syndrome	8.77e-06	0.00576	CrCbGaD
Imipramine—Dizziness—Pregabalin—epilepsy syndrome	8.74e-06	0.00016	CcSEcCtD
Imipramine—Constipation—Topiramate—epilepsy syndrome	8.72e-06	0.00016	CcSEcCtD
Imipramine—Asthenia—Gabapentin—epilepsy syndrome	8.69e-06	0.00016	CcSEcCtD
Imipramine—Nausea—Valproic Acid—epilepsy syndrome	8.68e-06	0.000159	CcSEcCtD
Imipramine—Trimipramine—ADRA2A—epilepsy syndrome	8.59e-06	0.00565	CrCbGaD
Imipramine—Pruritus—Gabapentin—epilepsy syndrome	8.57e-06	0.000157	CcSEcCtD
Imipramine—Pipotiazine—CYP2C19—epilepsy syndrome	8.54e-06	0.00561	CrCbGaD
Imipramine—Promazine—CHRM2—epilepsy syndrome	8.53e-06	0.0056	CrCbGaD
Imipramine—Vomiting—Pregabalin—epilepsy syndrome	8.4e-06	0.000154	CcSEcCtD
Imipramine—Feeling abnormal—Topiramate—epilepsy syndrome	8.4e-06	0.000154	CcSEcCtD
Imipramine—Methotrimeprazine—ADRA2A—epilepsy syndrome	8.4e-06	0.00552	CrCbGaD
Imipramine—Gastrointestinal pain—Topiramate—epilepsy syndrome	8.34e-06	0.000153	CcSEcCtD
Imipramine—Rash—Pregabalin—epilepsy syndrome	8.33e-06	0.000153	CcSEcCtD
Imipramine—Dermatitis—Pregabalin—epilepsy syndrome	8.32e-06	0.000153	CcSEcCtD
Imipramine—Diarrhoea—Gabapentin—epilepsy syndrome	8.29e-06	0.000152	CcSEcCtD
Imipramine—Headache—Pregabalin—epilepsy syndrome	8.28e-06	0.000152	CcSEcCtD
Imipramine—Doxepin—ADRA2A—epilepsy syndrome	8.19e-06	0.00538	CrCbGaD
Imipramine—Maprotiline—CYP2D6—epilepsy syndrome	8.14e-06	0.00535	CrCbGaD
Imipramine—Urticaria—Topiramate—epilepsy syndrome	8.1e-06	0.000149	CcSEcCtD
Imipramine—Body temperature increased—Topiramate—epilepsy syndrome	8.06e-06	0.000148	CcSEcCtD
Imipramine—Abdominal pain—Topiramate—epilepsy syndrome	8.06e-06	0.000148	CcSEcCtD
Imipramine—Dizziness—Gabapentin—epilepsy syndrome	8.01e-06	0.000147	CcSEcCtD
Imipramine—Carbamazepine—CYP2C19—epilepsy syndrome	8.01e-06	0.00527	CrCbGaD
Imipramine—Nausea—Pregabalin—epilepsy syndrome	7.85e-06	0.000144	CcSEcCtD
Imipramine—Mianserin—SLC6A4—epilepsy syndrome	7.79e-06	0.00512	CrCbGaD
Imipramine—Vomiting—Gabapentin—epilepsy syndrome	7.7e-06	0.000141	CcSEcCtD
Imipramine—Rash—Gabapentin—epilepsy syndrome	7.64e-06	0.00014	CcSEcCtD
Imipramine—Dermatitis—Gabapentin—epilepsy syndrome	7.63e-06	0.00014	CcSEcCtD
Imipramine—Headache—Gabapentin—epilepsy syndrome	7.59e-06	0.000139	CcSEcCtD
Imipramine—Chlorpromazine—CHRM2—epilepsy syndrome	7.5e-06	0.00493	CrCbGaD
Imipramine—Chlorpromazine—HTR7—epilepsy syndrome	7.47e-06	0.00491	CrCbGaD
Imipramine—Amitriptyline—CHRM2—epilepsy syndrome	7.42e-06	0.00488	CrCbGaD
Imipramine—Amitriptyline—HTR7—epilepsy syndrome	7.38e-06	0.00485	CrCbGaD
Imipramine—Asthenia—Topiramate—epilepsy syndrome	7.31e-06	0.000134	CcSEcCtD
Imipramine—Promazine—ADRA2A—epilepsy syndrome	7.28e-06	0.00478	CrCbGaD
Imipramine—Pruritus—Topiramate—epilepsy syndrome	7.21e-06	0.000132	CcSEcCtD
Imipramine—Acepromazine—HTR2A—epilepsy syndrome	7.2e-06	0.00473	CrCbGaD
Imipramine—Nausea—Gabapentin—epilepsy syndrome	7.2e-06	0.000132	CcSEcCtD
Imipramine—Clomipramine—SLC6A4—epilepsy syndrome	7.12e-06	0.00468	CrCbGaD
Imipramine—Thioproperazine—HTR2A—epilepsy syndrome	7.04e-06	0.00463	CrCbGaD
Imipramine—Diarrhoea—Topiramate—epilepsy syndrome	6.98e-06	0.000128	CcSEcCtD
Imipramine—Nortriptyline—SLC6A4—epilepsy syndrome	6.96e-06	0.00458	CrCbGaD
Imipramine—Pipotiazine—HTR2A—epilepsy syndrome	6.92e-06	0.00455	CrCbGaD
Imipramine—Epinastine—ABCB1—epilepsy syndrome	6.75e-06	0.00444	CrCbGaD
Imipramine—Clomipramine—CYP2C19—epilepsy syndrome	6.75e-06	0.00444	CrCbGaD
Imipramine—Dizziness—Topiramate—epilepsy syndrome	6.74e-06	0.000124	CcSEcCtD
Imipramine—Nortriptyline—CYP2C19—epilepsy syndrome	6.6e-06	0.00434	CrCbGaD
Imipramine—Trimipramine—SLC6A4—epilepsy syndrome	6.55e-06	0.00431	CrCbGaD
Imipramine—Oxcarbazepine—ALB—epilepsy syndrome	6.52e-06	0.00429	CrCbGaD
Imipramine—Vomiting—Topiramate—epilepsy syndrome	6.48e-06	0.000119	CcSEcCtD
Imipramine—Rash—Topiramate—epilepsy syndrome	6.43e-06	0.000118	CcSEcCtD
Imipramine—Dermatitis—Topiramate—epilepsy syndrome	6.42e-06	0.000118	CcSEcCtD
Imipramine—Chlorpromazine—ADRA2A—epilepsy syndrome	6.4e-06	0.00421	CrCbGaD
Imipramine—Headache—Topiramate—epilepsy syndrome	6.39e-06	0.000117	CcSEcCtD
Imipramine—Pipotiazine—CYP2D6—epilepsy syndrome	6.33e-06	0.00416	CrCbGaD
Imipramine—Amitriptyline—ADRA2A—epilepsy syndrome	6.33e-06	0.00416	CrCbGaD
Imipramine—Chlorpromazine—BCHE—epilepsy syndrome	6.26e-06	0.00411	CrCbGaD
Imipramine—Doxepin—SLC6A4—epilepsy syndrome	6.24e-06	0.00411	CrCbGaD
Imipramine—Trimipramine—CYP2C19—epilepsy syndrome	6.21e-06	0.00408	CrCbGaD
Imipramine—Diphenhydramine—CYP2C19—epilepsy syndrome	6.1e-06	0.00401	CrCbGaD
Imipramine—Nausea—Topiramate—epilepsy syndrome	6.06e-06	0.000111	CcSEcCtD
Imipramine—Prochlorperazine—CYP2D6—epilepsy syndrome	6.05e-06	0.00398	CrCbGaD
Imipramine—Mianserin—HTR2A—epilepsy syndrome	5.98e-06	0.00393	CrCbGaD
Imipramine—Doxepin—CYP2C19—epilepsy syndrome	5.92e-06	0.00389	CrCbGaD
Imipramine—Maprotiline—ABCB1—epilepsy syndrome	5.81e-06	0.00382	CrCbGaD
Imipramine—Desipramine—SLC6A4—epilepsy syndrome	5.73e-06	0.00377	CrCbGaD
Imipramine—Clomipramine—HTR2A—epilepsy syndrome	5.47e-06	0.0036	CrCbGaD
Imipramine—Mianserin—CYP2D6—epilepsy syndrome	5.47e-06	0.0036	CrCbGaD
Imipramine—Desipramine—CYP2C19—epilepsy syndrome	5.43e-06	0.00357	CrCbGaD
Imipramine—Nortriptyline—HTR2A—epilepsy syndrome	5.35e-06	0.00352	CrCbGaD
Imipramine—Promazine—CYP2C19—epilepsy syndrome	5.26e-06	0.00346	CrCbGaD
Imipramine—Triflupromazine—ABCB1—epilepsy syndrome	5.08e-06	0.00334	CrCbGaD
Imipramine—Trimipramine—HTR2A—epilepsy syndrome	5.04e-06	0.00331	CrCbGaD
Imipramine—Clomipramine—CYP2D6—epilepsy syndrome	5.01e-06	0.00329	CrCbGaD
Imipramine—Acepromazine—ALB—epilepsy syndrome	4.93e-06	0.00324	CrCbGaD
Imipramine—Methotrimeprazine—HTR2A—epilepsy syndrome	4.92e-06	0.00324	CrCbGaD
Imipramine—Nortriptyline—CYP2D6—epilepsy syndrome	4.89e-06	0.00322	CrCbGaD
Imipramine—Promethazine—HTR2A—epilepsy syndrome	4.85e-06	0.00319	CrCbGaD
Imipramine—Amitriptyline—SLC6A4—epilepsy syndrome	4.83e-06	0.00317	CrCbGaD
Imipramine—Thioproperazine—ALB—epilepsy syndrome	4.82e-06	0.00317	CrCbGaD
Imipramine—Doxepin—HTR2A—epilepsy syndrome	4.8e-06	0.00315	CrCbGaD
Imipramine—Pipotiazine—ALB—epilepsy syndrome	4.74e-06	0.00311	CrCbGaD
Imipramine—Trimipramine—CYP2D6—epilepsy syndrome	4.61e-06	0.00303	CrCbGaD
Imipramine—Amitriptyline—CYP2C19—epilepsy syndrome	4.58e-06	0.00301	CrCbGaD
Imipramine—Diphenhydramine—CYP2D6—epilepsy syndrome	4.52e-06	0.00297	CrCbGaD
Imipramine—Methotrimeprazine—CYP2D6—epilepsy syndrome	4.5e-06	0.00296	CrCbGaD
Imipramine—Promethazine—CYP2D6—epilepsy syndrome	4.43e-06	0.00291	CrCbGaD
Imipramine—Desipramine—HTR2A—epilepsy syndrome	4.4e-06	0.00289	CrCbGaD
Imipramine—Doxepin—CYP2D6—epilepsy syndrome	4.39e-06	0.00289	CrCbGaD
Imipramine—Promazine—HTR2A—epilepsy syndrome	4.27e-06	0.0028	CrCbGaD
Imipramine—Carbamazepine—ABCB1—epilepsy syndrome	4.24e-06	0.00279	CrCbGaD
Imipramine—Desipramine—CYP2D6—epilepsy syndrome	4.03e-06	0.00265	CrCbGaD
Imipramine—Chlorpromazine—HTR2A—epilepsy syndrome	3.75e-06	0.00247	CrCbGaD
Imipramine—Clomipramine—ALB—epilepsy syndrome	3.75e-06	0.00246	CrCbGaD
Imipramine—Amitriptyline—HTR2A—epilepsy syndrome	3.71e-06	0.00244	CrCbGaD
Imipramine—Nortriptyline—ALB—epilepsy syndrome	3.66e-06	0.00241	CrCbGaD
Imipramine—Clomipramine—ABCB1—epilepsy syndrome	3.57e-06	0.00235	CrCbGaD
Imipramine—Chlorpromazine—CYP2D6—epilepsy syndrome	3.43e-06	0.00226	CrCbGaD
Imipramine—Amitriptyline—CYP2D6—epilepsy syndrome	3.39e-06	0.00223	CrCbGaD
Imipramine—Trimipramine—ABCB1—epilepsy syndrome	3.29e-06	0.00216	CrCbGaD
Imipramine—Promethazine—ABCB1—epilepsy syndrome	3.17e-06	0.00208	CrCbGaD
Imipramine—Doxepin—ABCB1—epilepsy syndrome	3.13e-06	0.00206	CrCbGaD
Imipramine—Desipramine—ABCB1—epilepsy syndrome	2.88e-06	0.00189	CrCbGaD
Imipramine—Chlorpromazine—ALB—epilepsy syndrome	2.57e-06	0.00169	CrCbGaD
Imipramine—Amitriptyline—ALB—epilepsy syndrome	2.54e-06	0.00167	CrCbGaD
Imipramine—Chlorpromazine—ABCB1—epilepsy syndrome	2.45e-06	0.00161	CrCbGaD
Imipramine—Amitriptyline—ABCB1—epilepsy syndrome	2.42e-06	0.00159	CrCbGaD
Imipramine—CYP1A2—Metabolism—SLC2A1—epilepsy syndrome	2.85e-07	6.94e-06	CbGpPWpGaD
Imipramine—ADRA1B—Signaling Pathways—POMC—epilepsy syndrome	2.83e-07	6.9e-06	CbGpPWpGaD
Imipramine—CHRM4—GPCR downstream signaling—AKT1—epilepsy syndrome	2.83e-07	6.9e-06	CbGpPWpGaD
Imipramine—CYP3A7—Metabolism—PTGS2—epilepsy syndrome	2.82e-07	6.89e-06	CbGpPWpGaD
Imipramine—SLC22A2—Metabolism—PTGS2—epilepsy syndrome	2.82e-07	6.87e-06	CbGpPWpGaD
Imipramine—HTR2A—Signaling Pathways—PRKCB—epilepsy syndrome	2.82e-07	6.87e-06	CbGpPWpGaD
Imipramine—CYP1A2—Metabolism—PLCB1—epilepsy syndrome	2.82e-07	6.86e-06	CbGpPWpGaD
Imipramine—HRH1—Signaling Pathways—PRKCB—epilepsy syndrome	2.81e-07	6.86e-06	CbGpPWpGaD
Imipramine—HTR6—Signaling Pathways—MMP9—epilepsy syndrome	2.81e-07	6.85e-06	CbGpPWpGaD
Imipramine—HTR2A—Signaling Pathways—IL6ST—epilepsy syndrome	2.81e-07	6.84e-06	CbGpPWpGaD
Imipramine—HTR7—Signaling Pathways—MMP9—epilepsy syndrome	2.81e-07	6.84e-06	CbGpPWpGaD
Imipramine—CYP1A2—Metabolism—TH—epilepsy syndrome	2.81e-07	6.84e-06	CbGpPWpGaD
Imipramine—CHRM4—Signaling Pathways—CASP3—epilepsy syndrome	2.8e-07	6.84e-06	CbGpPWpGaD
Imipramine—CHRM1—Signaling Pathways—PRKCB—epilepsy syndrome	2.8e-07	6.83e-06	CbGpPWpGaD
Imipramine—HRH1—Signaling Pathways—IL6ST—epilepsy syndrome	2.8e-07	6.83e-06	CbGpPWpGaD
Imipramine—ADRA1D—Signaling Pathways—RELA—epilepsy syndrome	2.8e-07	6.82e-06	CbGpPWpGaD
Imipramine—CHRM3—Signaling Pathways—PRKCB—epilepsy syndrome	2.79e-07	6.81e-06	CbGpPWpGaD
Imipramine—CHRM1—Signaling Pathways—IL6ST—epilepsy syndrome	2.79e-07	6.81e-06	CbGpPWpGaD
Imipramine—CHRM3—Signaling Pathways—IL6ST—epilepsy syndrome	2.78e-07	6.78e-06	CbGpPWpGaD
Imipramine—CYP3A4—Metabolism—ABCG2—epilepsy syndrome	2.78e-07	6.77e-06	CbGpPWpGaD
Imipramine—CHRM3—Metabolism—ALB—epilepsy syndrome	2.78e-07	6.77e-06	CbGpPWpGaD
Imipramine—ADRA1B—Signaling Pathways—CCL2—epilepsy syndrome	2.77e-07	6.75e-06	CbGpPWpGaD
Imipramine—CHRM2—Signaling Pathways—PRKCB—epilepsy syndrome	2.77e-07	6.75e-06	CbGpPWpGaD
Imipramine—CYP2D6—Metabolism—HMOX1—epilepsy syndrome	2.76e-07	6.74e-06	CbGpPWpGaD
Imipramine—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—epilepsy syndrome	2.76e-07	6.73e-06	CbGpPWpGaD
Imipramine—ADRA1A—Signaling Pathways—PRKCB—epilepsy syndrome	2.76e-07	6.73e-06	CbGpPWpGaD
Imipramine—CHRM2—Signaling Pathways—IL6ST—epilepsy syndrome	2.76e-07	6.72e-06	CbGpPWpGaD
Imipramine—ADRA1A—Signaling Pathways—IL6ST—epilepsy syndrome	2.75e-07	6.7e-06	CbGpPWpGaD
Imipramine—ADRA1D—Signaling Pathways—MTOR—epilepsy syndrome	2.75e-07	6.69e-06	CbGpPWpGaD
Imipramine—CYP2D6—Metabolism—CAT—epilepsy syndrome	2.73e-07	6.65e-06	CbGpPWpGaD
Imipramine—HTR6—Signaling by GPCR—AKT1—epilepsy syndrome	2.72e-07	6.64e-06	CbGpPWpGaD
Imipramine—CHRM4—Signaling Pathways—JUN—epilepsy syndrome	2.72e-07	6.64e-06	CbGpPWpGaD
Imipramine—HTR7—Signaling by GPCR—AKT1—epilepsy syndrome	2.72e-07	6.63e-06	CbGpPWpGaD
Imipramine—CHRM5—GPCR downstream signaling—AKT1—epilepsy syndrome	2.71e-07	6.61e-06	CbGpPWpGaD
Imipramine—CYP3A4—Metabolism—CYP2C19—epilepsy syndrome	2.71e-07	6.6e-06	CbGpPWpGaD
Imipramine—CYP3A4—Metabolism—CYP11A1—epilepsy syndrome	2.69e-07	6.56e-06	CbGpPWpGaD
Imipramine—CHRM5—Signaling Pathways—CASP3—epilepsy syndrome	2.69e-07	6.55e-06	CbGpPWpGaD
Imipramine—CYP2C19—Metabolism—GPX1—epilepsy syndrome	2.68e-07	6.54e-06	CbGpPWpGaD
Imipramine—CYP2D6—Metabolism—ABCB1—epilepsy syndrome	2.65e-07	6.47e-06	CbGpPWpGaD
Imipramine—CHRM4—Signaling Pathways—MMP9—epilepsy syndrome	2.65e-07	6.46e-06	CbGpPWpGaD
Imipramine—SLC22A1—Metabolism—PTGS2—epilepsy syndrome	2.63e-07	6.41e-06	CbGpPWpGaD
Imipramine—HTR1A—Signaling Pathways—FGF2—epilepsy syndrome	2.63e-07	6.41e-06	CbGpPWpGaD
Imipramine—CYP2B6—Metabolism—POMC—epilepsy syndrome	2.62e-07	6.38e-06	CbGpPWpGaD
Imipramine—ABCB1—Metabolism—GPX1—epilepsy syndrome	2.62e-07	6.38e-06	CbGpPWpGaD
Imipramine—HTR2C—Signaling Pathways—FGF2—epilepsy syndrome	2.61e-07	6.37e-06	CbGpPWpGaD
Imipramine—DRD2—Signaling Pathways—POMC—epilepsy syndrome	2.61e-07	6.36e-06	CbGpPWpGaD
Imipramine—CHRM5—Signaling Pathways—JUN—epilepsy syndrome	2.61e-07	6.36e-06	CbGpPWpGaD
Imipramine—HTR6—Signaling Pathways—SRC—epilepsy syndrome	2.59e-07	6.31e-06	CbGpPWpGaD
Imipramine—HTR7—Signaling Pathways—SRC—epilepsy syndrome	2.59e-07	6.31e-06	CbGpPWpGaD
Imipramine—CHRM4—Signaling by GPCR—AKT1—epilepsy syndrome	2.57e-07	6.26e-06	CbGpPWpGaD
Imipramine—HTR2A—Signaling Pathways—POMC—epilepsy syndrome	2.57e-07	6.26e-06	CbGpPWpGaD
Imipramine—CYP2E1—Metabolism—POMC—epilepsy syndrome	2.57e-07	6.25e-06	CbGpPWpGaD
Imipramine—HRH1—Signaling Pathways—POMC—epilepsy syndrome	2.56e-07	6.25e-06	CbGpPWpGaD
Imipramine—CHRM1—Signaling Pathways—POMC—epilepsy syndrome	2.55e-07	6.22e-06	CbGpPWpGaD
Imipramine—DRD2—Signaling Pathways—CCL2—epilepsy syndrome	2.55e-07	6.22e-06	CbGpPWpGaD
Imipramine—ADRA1D—GPCR downstream signaling—AKT1—epilepsy syndrome	2.55e-07	6.21e-06	CbGpPWpGaD
Imipramine—CHRM3—Signaling Pathways—POMC—epilepsy syndrome	2.55e-07	6.21e-06	CbGpPWpGaD
Imipramine—CHRM5—Signaling Pathways—MMP9—epilepsy syndrome	2.54e-07	6.19e-06	CbGpPWpGaD
Imipramine—ADRA1D—Signaling Pathways—CASP3—epilepsy syndrome	2.53e-07	6.15e-06	CbGpPWpGaD
Imipramine—HTR6—Signaling Pathways—VEGFA—epilepsy syndrome	2.52e-07	6.15e-06	CbGpPWpGaD
Imipramine—CHRM2—Signaling Pathways—POMC—epilepsy syndrome	2.52e-07	6.14e-06	CbGpPWpGaD
Imipramine—HTR7—Signaling Pathways—VEGFA—epilepsy syndrome	2.52e-07	6.14e-06	CbGpPWpGaD
Imipramine—ADRA1A—Signaling Pathways—POMC—epilepsy syndrome	2.51e-07	6.13e-06	CbGpPWpGaD
Imipramine—HTR2A—Signaling Pathways—CCL2—epilepsy syndrome	2.51e-07	6.12e-06	CbGpPWpGaD
Imipramine—HRH1—Signaling Pathways—CCL2—epilepsy syndrome	2.51e-07	6.11e-06	CbGpPWpGaD
Imipramine—ADRA1B—Signaling Pathways—FGF2—epilepsy syndrome	2.5e-07	6.1e-06	CbGpPWpGaD
Imipramine—CHRM1—Signaling Pathways—CCL2—epilepsy syndrome	2.5e-07	6.09e-06	CbGpPWpGaD
Imipramine—CHRM3—Signaling Pathways—CCL2—epilepsy syndrome	2.49e-07	6.07e-06	CbGpPWpGaD
Imipramine—CHRM2—Signaling Pathways—CCL2—epilepsy syndrome	2.47e-07	6.01e-06	CbGpPWpGaD
Imipramine—CYP2D6—Metabolism—GPX1—epilepsy syndrome	2.47e-07	6.01e-06	CbGpPWpGaD
Imipramine—CHRM5—Signaling by GPCR—AKT1—epilepsy syndrome	2.46e-07	6e-06	CbGpPWpGaD
Imipramine—ADRA1A—Signaling Pathways—CCL2—epilepsy syndrome	2.46e-07	6e-06	CbGpPWpGaD
Imipramine—ADRA1D—Signaling Pathways—JUN—epilepsy syndrome	2.45e-07	5.98e-06	CbGpPWpGaD
Imipramine—CHRM4—Signaling Pathways—SRC—epilepsy syndrome	2.44e-07	5.96e-06	CbGpPWpGaD
Imipramine—HTR1A—Signaling Pathways—RELA—epilepsy syndrome	2.44e-07	5.95e-06	CbGpPWpGaD
Imipramine—CYP3A4—Metabolism—CYP2D6—epilepsy syndrome	2.43e-07	5.92e-06	CbGpPWpGaD
Imipramine—CHRM3—Metabolism—PTGS2—epilepsy syndrome	2.43e-07	5.92e-06	CbGpPWpGaD
Imipramine—HTR2C—Signaling Pathways—RELA—epilepsy syndrome	2.43e-07	5.92e-06	CbGpPWpGaD
Imipramine—HTR1A—Signaling Pathways—MTOR—epilepsy syndrome	2.39e-07	5.83e-06	CbGpPWpGaD
Imipramine—CYP2B6—Metabolism—ALB—epilepsy syndrome	2.39e-07	5.82e-06	CbGpPWpGaD
Imipramine—ADRA1D—Signaling Pathways—MMP9—epilepsy syndrome	2.39e-07	5.82e-06	CbGpPWpGaD
Imipramine—HTR2C—Signaling Pathways—MTOR—epilepsy syndrome	2.38e-07	5.8e-06	CbGpPWpGaD
Imipramine—CHRM4—Signaling Pathways—VEGFA—epilepsy syndrome	2.38e-07	5.8e-06	CbGpPWpGaD
Imipramine—CYP2C19—Metabolism—AGT—epilepsy syndrome	2.35e-07	5.73e-06	CbGpPWpGaD
Imipramine—CYP1A2—Metabolism—HMOX1—epilepsy syndrome	2.34e-07	5.71e-06	CbGpPWpGaD
Imipramine—CHRM5—Signaling Pathways—SRC—epilepsy syndrome	2.34e-07	5.7e-06	CbGpPWpGaD
Imipramine—CYP2E1—Metabolism—ALB—epilepsy syndrome	2.34e-07	5.7e-06	CbGpPWpGaD
Imipramine—ADRA1B—Signaling Pathways—RELA—epilepsy syndrome	2.32e-07	5.66e-06	CbGpPWpGaD
Imipramine—ADRA1D—Signaling by GPCR—AKT1—epilepsy syndrome	2.31e-07	5.64e-06	CbGpPWpGaD
Imipramine—CYP3A4—Metabolism—ADRA2A—epilepsy syndrome	2.31e-07	5.64e-06	CbGpPWpGaD
Imipramine—CYP1A2—Metabolism—CAT—epilepsy syndrome	2.31e-07	5.63e-06	CbGpPWpGaD
Imipramine—DRD2—Signaling Pathways—FGF2—epilepsy syndrome	2.31e-07	5.62e-06	CbGpPWpGaD
Imipramine—CYP2C19—Metabolism—APOE—epilepsy syndrome	2.3e-07	5.62e-06	CbGpPWpGaD
Imipramine—CYP3A4—Metabolism—BCHE—epilepsy syndrome	2.3e-07	5.61e-06	CbGpPWpGaD
Imipramine—ABCB1—Metabolism—AGT—epilepsy syndrome	2.3e-07	5.59e-06	CbGpPWpGaD
Imipramine—CHRM5—Signaling Pathways—VEGFA—epilepsy syndrome	2.28e-07	5.55e-06	CbGpPWpGaD
Imipramine—ADRA1B—Signaling Pathways—MTOR—epilepsy syndrome	2.28e-07	5.55e-06	CbGpPWpGaD
Imipramine—HTR2A—Signaling Pathways—FGF2—epilepsy syndrome	2.27e-07	5.53e-06	CbGpPWpGaD
Imipramine—HRH1—Signaling Pathways—FGF2—epilepsy syndrome	2.27e-07	5.52e-06	CbGpPWpGaD
Imipramine—SLC22A3—Metabolism—AKT1—epilepsy syndrome	2.26e-07	5.51e-06	CbGpPWpGaD
Imipramine—CHRM1—Signaling Pathways—FGF2—epilepsy syndrome	2.26e-07	5.5e-06	CbGpPWpGaD
Imipramine—CHRM3—Signaling Pathways—FGF2—epilepsy syndrome	2.25e-07	5.49e-06	CbGpPWpGaD
Imipramine—ABCB1—Metabolism—APOE—epilepsy syndrome	2.25e-07	5.48e-06	CbGpPWpGaD
Imipramine—CYP1A2—Metabolism—ABCB1—epilepsy syndrome	2.25e-07	5.48e-06	CbGpPWpGaD
Imipramine—CHRM2—Signaling Pathways—FGF2—epilepsy syndrome	2.23e-07	5.43e-06	CbGpPWpGaD
Imipramine—ADRA1A—Signaling Pathways—FGF2—epilepsy syndrome	2.22e-07	5.42e-06	CbGpPWpGaD
Imipramine—HTR1A—GPCR downstream signaling—AKT1—epilepsy syndrome	2.22e-07	5.41e-06	CbGpPWpGaD
Imipramine—HTR2C—GPCR downstream signaling—AKT1—epilepsy syndrome	2.21e-07	5.39e-06	CbGpPWpGaD
Imipramine—HTR1A—Signaling Pathways—CASP3—epilepsy syndrome	2.2e-07	5.36e-06	CbGpPWpGaD
Imipramine—ADRA1D—Signaling Pathways—SRC—epilepsy syndrome	2.2e-07	5.36e-06	CbGpPWpGaD
Imipramine—CYP3A4—Metabolism—SLC2A1—epilepsy syndrome	2.2e-07	5.36e-06	CbGpPWpGaD
Imipramine—HTR2C—Signaling Pathways—CASP3—epilepsy syndrome	2.19e-07	5.34e-06	CbGpPWpGaD
Imipramine—CYP3A4—Metabolism—PLCB1—epilepsy syndrome	2.17e-07	5.3e-06	CbGpPWpGaD
Imipramine—CYP3A4—Metabolism—TH—epilepsy syndrome	2.17e-07	5.28e-06	CbGpPWpGaD
Imipramine—CYP2D6—Metabolism—AGT—epilepsy syndrome	2.16e-07	5.27e-06	CbGpPWpGaD
Imipramine—ADRA1D—Signaling Pathways—VEGFA—epilepsy syndrome	2.14e-07	5.22e-06	CbGpPWpGaD
Imipramine—DRD2—Signaling Pathways—RELA—epilepsy syndrome	2.14e-07	5.22e-06	CbGpPWpGaD
Imipramine—HTR1A—Signaling Pathways—JUN—epilepsy syndrome	2.14e-07	5.21e-06	CbGpPWpGaD
Imipramine—CYP2C18—Metabolism—AKT1—epilepsy syndrome	2.14e-07	5.21e-06	CbGpPWpGaD
Imipramine—HTR2C—Signaling Pathways—JUN—epilepsy syndrome	2.13e-07	5.18e-06	CbGpPWpGaD
Imipramine—CYP2D6—Metabolism—APOE—epilepsy syndrome	2.12e-07	5.17e-06	CbGpPWpGaD
Imipramine—ADRA1B—GPCR downstream signaling—AKT1—epilepsy syndrome	2.12e-07	5.16e-06	CbGpPWpGaD
Imipramine—HTR2A—Signaling Pathways—RELA—epilepsy syndrome	2.11e-07	5.14e-06	CbGpPWpGaD
Imipramine—HRH1—Signaling Pathways—RELA—epilepsy syndrome	2.1e-07	5.13e-06	CbGpPWpGaD
Imipramine—DRD2—Signaling Pathways—MTOR—epilepsy syndrome	2.1e-07	5.12e-06	CbGpPWpGaD
Imipramine—CHRM1—Signaling Pathways—RELA—epilepsy syndrome	2.1e-07	5.11e-06	CbGpPWpGaD
Imipramine—ADRA1B—Signaling Pathways—CASP3—epilepsy syndrome	2.1e-07	5.11e-06	CbGpPWpGaD
Imipramine—CHRM3—Signaling Pathways—RELA—epilepsy syndrome	2.09e-07	5.09e-06	CbGpPWpGaD
Imipramine—CYP1A2—Metabolism—GPX1—epilepsy syndrome	2.09e-07	5.09e-06	CbGpPWpGaD
Imipramine—CYP2B6—Metabolism—PTGS2—epilepsy syndrome	2.09e-07	5.09e-06	CbGpPWpGaD
Imipramine—HTR1A—Signaling Pathways—MMP9—epilepsy syndrome	2.08e-07	5.07e-06	CbGpPWpGaD
Imipramine—CHRM2—Signaling Pathways—RELA—epilepsy syndrome	2.07e-07	5.04e-06	CbGpPWpGaD
Imipramine—HTR2C—Signaling Pathways—MMP9—epilepsy syndrome	2.07e-07	5.04e-06	CbGpPWpGaD
Imipramine—HTR2A—Signaling Pathways—MTOR—epilepsy syndrome	2.07e-07	5.04e-06	CbGpPWpGaD
Imipramine—ADRA1A—Signaling Pathways—RELA—epilepsy syndrome	2.06e-07	5.03e-06	CbGpPWpGaD
Imipramine—HRH1—Signaling Pathways—MTOR—epilepsy syndrome	2.06e-07	5.03e-06	CbGpPWpGaD
Imipramine—CHRM1—Signaling Pathways—MTOR—epilepsy syndrome	2.06e-07	5.01e-06	CbGpPWpGaD
Imipramine—CHRM3—Signaling Pathways—MTOR—epilepsy syndrome	2.05e-07	5e-06	CbGpPWpGaD
Imipramine—CYP2E1—Metabolism—PTGS2—epilepsy syndrome	2.05e-07	4.99e-06	CbGpPWpGaD
Imipramine—ADRA1B—Signaling Pathways—JUN—epilepsy syndrome	2.04e-07	4.96e-06	CbGpPWpGaD
Imipramine—CHRM2—Signaling Pathways—MTOR—epilepsy syndrome	2.03e-07	4.95e-06	CbGpPWpGaD
Imipramine—ADRA1A—Signaling Pathways—MTOR—epilepsy syndrome	2.02e-07	4.93e-06	CbGpPWpGaD
Imipramine—HTR1A—Signaling by GPCR—AKT1—epilepsy syndrome	2.02e-07	4.92e-06	CbGpPWpGaD
Imipramine—HTR2C—Signaling by GPCR—AKT1—epilepsy syndrome	2.01e-07	4.89e-06	CbGpPWpGaD
Imipramine—ADRA1B—Signaling Pathways—MMP9—epilepsy syndrome	1.98e-07	4.83e-06	CbGpPWpGaD
Imipramine—CYP2C19—Metabolism—POMC—epilepsy syndrome	1.98e-07	4.82e-06	CbGpPWpGaD
Imipramine—DRD2—GPCR downstream signaling—AKT1—epilepsy syndrome	1.95e-07	4.75e-06	CbGpPWpGaD
Imipramine—DRD2—Signaling Pathways—CASP3—epilepsy syndrome	1.93e-07	4.71e-06	CbGpPWpGaD
Imipramine—ABCB1—Metabolism—POMC—epilepsy syndrome	1.93e-07	4.71e-06	CbGpPWpGaD
Imipramine—ADRA1B—Signaling by GPCR—AKT1—epilepsy syndrome	1.92e-07	4.68e-06	CbGpPWpGaD
Imipramine—HTR2A—GPCR downstream signaling—AKT1—epilepsy syndrome	1.92e-07	4.68e-06	CbGpPWpGaD
Imipramine—HTR1A—Signaling Pathways—SRC—epilepsy syndrome	1.92e-07	4.67e-06	CbGpPWpGaD
Imipramine—HRH1—GPCR downstream signaling—AKT1—epilepsy syndrome	1.91e-07	4.67e-06	CbGpPWpGaD
Imipramine—CHRM1—GPCR downstream signaling—AKT1—epilepsy syndrome	1.91e-07	4.65e-06	CbGpPWpGaD
Imipramine—HTR2C—Signaling Pathways—SRC—epilepsy syndrome	1.91e-07	4.65e-06	CbGpPWpGaD
Imipramine—CHRM3—GPCR downstream signaling—AKT1—epilepsy syndrome	1.9e-07	4.64e-06	CbGpPWpGaD
Imipramine—HTR2A—Signaling Pathways—CASP3—epilepsy syndrome	1.9e-07	4.63e-06	CbGpPWpGaD
Imipramine—HRH1—Signaling Pathways—CASP3—epilepsy syndrome	1.9e-07	4.62e-06	CbGpPWpGaD
Imipramine—CHRM1—Signaling Pathways—CASP3—epilepsy syndrome	1.89e-07	4.61e-06	CbGpPWpGaD
Imipramine—CHRM3—Signaling Pathways—CASP3—epilepsy syndrome	1.88e-07	4.59e-06	CbGpPWpGaD
Imipramine—CHRM2—GPCR downstream signaling—AKT1—epilepsy syndrome	1.88e-07	4.59e-06	CbGpPWpGaD
Imipramine—ADRA1A—GPCR downstream signaling—AKT1—epilepsy syndrome	1.88e-07	4.58e-06	CbGpPWpGaD
Imipramine—DRD2—Signaling Pathways—JUN—epilepsy syndrome	1.88e-07	4.57e-06	CbGpPWpGaD
Imipramine—HTR1A—Signaling Pathways—VEGFA—epilepsy syndrome	1.87e-07	4.55e-06	CbGpPWpGaD
Imipramine—CHRM2—Signaling Pathways—CASP3—epilepsy syndrome	1.87e-07	4.55e-06	CbGpPWpGaD
Imipramine—ADRA1A—Signaling Pathways—CASP3—epilepsy syndrome	1.86e-07	4.54e-06	CbGpPWpGaD
Imipramine—HTR2C—Signaling Pathways—VEGFA—epilepsy syndrome	1.86e-07	4.53e-06	CbGpPWpGaD
Imipramine—HTR2A—Signaling Pathways—JUN—epilepsy syndrome	1.85e-07	4.5e-06	CbGpPWpGaD
Imipramine—HRH1—Signaling Pathways—JUN—epilepsy syndrome	1.84e-07	4.49e-06	CbGpPWpGaD
Imipramine—CHRM1—Signaling Pathways—JUN—epilepsy syndrome	1.84e-07	4.48e-06	CbGpPWpGaD
Imipramine—CYP1A2—Metabolism—AGT—epilepsy syndrome	1.83e-07	4.47e-06	CbGpPWpGaD
Imipramine—CHRM3—Signaling Pathways—JUN—epilepsy syndrome	1.83e-07	4.46e-06	CbGpPWpGaD
Imipramine—ADRA1B—Signaling Pathways—SRC—epilepsy syndrome	1.83e-07	4.45e-06	CbGpPWpGaD
Imipramine—DRD2—Signaling Pathways—MMP9—epilepsy syndrome	1.83e-07	4.45e-06	CbGpPWpGaD
Imipramine—CYP2D6—Metabolism—POMC—epilepsy syndrome	1.82e-07	4.44e-06	CbGpPWpGaD
Imipramine—CHRM2—Signaling Pathways—JUN—epilepsy syndrome	1.81e-07	4.42e-06	CbGpPWpGaD
Imipramine—ADRA1A—Signaling Pathways—JUN—epilepsy syndrome	1.81e-07	4.41e-06	CbGpPWpGaD
Imipramine—CYP3A4—Metabolism—HMOX1—epilepsy syndrome	1.81e-07	4.4e-06	CbGpPWpGaD
Imipramine—CYP2C19—Metabolism—ALB—epilepsy syndrome	1.8e-07	4.4e-06	CbGpPWpGaD
Imipramine—HTR2A—Signaling Pathways—MMP9—epilepsy syndrome	1.8e-07	4.38e-06	CbGpPWpGaD
Imipramine—CYP1A2—Metabolism—APOE—epilepsy syndrome	1.8e-07	4.38e-06	CbGpPWpGaD
Imipramine—HRH1—Signaling Pathways—MMP9—epilepsy syndrome	1.79e-07	4.37e-06	CbGpPWpGaD
Imipramine—CHRM1—Signaling Pathways—MMP9—epilepsy syndrome	1.79e-07	4.36e-06	CbGpPWpGaD
Imipramine—CYP3A4—Metabolism—CAT—epilepsy syndrome	1.78e-07	4.35e-06	CbGpPWpGaD
Imipramine—CHRM3—Signaling Pathways—MMP9—epilepsy syndrome	1.78e-07	4.34e-06	CbGpPWpGaD
Imipramine—ADRA1B—Signaling Pathways—VEGFA—epilepsy syndrome	1.78e-07	4.33e-06	CbGpPWpGaD
Imipramine—DRD2—Signaling by GPCR—AKT1—epilepsy syndrome	1.77e-07	4.32e-06	CbGpPWpGaD
Imipramine—CHRM2—Signaling Pathways—MMP9—epilepsy syndrome	1.76e-07	4.3e-06	CbGpPWpGaD
Imipramine—ABCB1—Metabolism—ALB—epilepsy syndrome	1.76e-07	4.29e-06	CbGpPWpGaD
Imipramine—ADRA1A—Signaling Pathways—MMP9—epilepsy syndrome	1.76e-07	4.29e-06	CbGpPWpGaD
Imipramine—HTR2A—Signaling by GPCR—AKT1—epilepsy syndrome	1.74e-07	4.25e-06	CbGpPWpGaD
Imipramine—HRH1—Signaling by GPCR—AKT1—epilepsy syndrome	1.74e-07	4.24e-06	CbGpPWpGaD
Imipramine—CYP3A4—Metabolism—ABCB1—epilepsy syndrome	1.73e-07	4.23e-06	CbGpPWpGaD
Imipramine—CHRM1—Signaling by GPCR—AKT1—epilepsy syndrome	1.73e-07	4.22e-06	CbGpPWpGaD
Imipramine—CHRM3—Signaling by GPCR—AKT1—epilepsy syndrome	1.73e-07	4.21e-06	CbGpPWpGaD
Imipramine—CHRM2—Signaling by GPCR—AKT1—epilepsy syndrome	1.71e-07	4.17e-06	CbGpPWpGaD
Imipramine—ADRA1A—Signaling by GPCR—AKT1—epilepsy syndrome	1.71e-07	4.16e-06	CbGpPWpGaD
Imipramine—DRD2—Signaling Pathways—SRC—epilepsy syndrome	1.68e-07	4.1e-06	CbGpPWpGaD
Imipramine—CYP2D6—Metabolism—ALB—epilepsy syndrome	1.66e-07	4.05e-06	CbGpPWpGaD
Imipramine—HTR2A—Signaling Pathways—SRC—epilepsy syndrome	1.66e-07	4.04e-06	CbGpPWpGaD
Imipramine—HRH1—Signaling Pathways—SRC—epilepsy syndrome	1.65e-07	4.03e-06	CbGpPWpGaD
Imipramine—CHRM1—Signaling Pathways—SRC—epilepsy syndrome	1.65e-07	4.02e-06	CbGpPWpGaD
Imipramine—CHRM3—Signaling Pathways—SRC—epilepsy syndrome	1.64e-07	4e-06	CbGpPWpGaD
Imipramine—DRD2—Signaling Pathways—VEGFA—epilepsy syndrome	1.64e-07	4e-06	CbGpPWpGaD
Imipramine—CHRM2—Signaling Pathways—SRC—epilepsy syndrome	1.63e-07	3.96e-06	CbGpPWpGaD
Imipramine—ADRA1A—Signaling Pathways—SRC—epilepsy syndrome	1.62e-07	3.95e-06	CbGpPWpGaD
Imipramine—HTR2A—Signaling Pathways—VEGFA—epilepsy syndrome	1.61e-07	3.93e-06	CbGpPWpGaD
Imipramine—CYP3A4—Metabolism—GPX1—epilepsy syndrome	1.61e-07	3.93e-06	CbGpPWpGaD
Imipramine—HRH1—Signaling Pathways—VEGFA—epilepsy syndrome	1.61e-07	3.92e-06	CbGpPWpGaD
Imipramine—HTR6—Signaling Pathways—AKT1—epilepsy syndrome	1.61e-07	3.92e-06	CbGpPWpGaD
Imipramine—HTR7—Signaling Pathways—AKT1—epilepsy syndrome	1.61e-07	3.92e-06	CbGpPWpGaD
Imipramine—CHRM1—Signaling Pathways—VEGFA—epilepsy syndrome	1.6e-07	3.91e-06	CbGpPWpGaD
Imipramine—CHRM3—Signaling Pathways—VEGFA—epilepsy syndrome	1.6e-07	3.9e-06	CbGpPWpGaD
Imipramine—CHRM2—Signaling Pathways—VEGFA—epilepsy syndrome	1.58e-07	3.86e-06	CbGpPWpGaD
Imipramine—ADRA1A—Signaling Pathways—VEGFA—epilepsy syndrome	1.58e-07	3.85e-06	CbGpPWpGaD
Imipramine—CYP2C19—Metabolism—PTGS2—epilepsy syndrome	1.58e-07	3.85e-06	CbGpPWpGaD
Imipramine—CYP1A2—Metabolism—POMC—epilepsy syndrome	1.54e-07	3.76e-06	CbGpPWpGaD
Imipramine—ABCB1—Metabolism—PTGS2—epilepsy syndrome	1.54e-07	3.76e-06	CbGpPWpGaD
Imipramine—CHRM4—Signaling Pathways—AKT1—epilepsy syndrome	1.52e-07	3.7e-06	CbGpPWpGaD
Imipramine—CHRM5—Signaling Pathways—AKT1—epilepsy syndrome	1.45e-07	3.54e-06	CbGpPWpGaD
Imipramine—CYP2D6—Metabolism—PTGS2—epilepsy syndrome	1.45e-07	3.54e-06	CbGpPWpGaD
Imipramine—CYP3A7—Metabolism—AKT1—epilepsy syndrome	1.42e-07	3.46e-06	CbGpPWpGaD
Imipramine—SLC22A2—Metabolism—AKT1—epilepsy syndrome	1.42e-07	3.46e-06	CbGpPWpGaD
Imipramine—CYP3A4—Metabolism—AGT—epilepsy syndrome	1.41e-07	3.45e-06	CbGpPWpGaD
Imipramine—CYP1A2—Metabolism—ALB—epilepsy syndrome	1.41e-07	3.43e-06	CbGpPWpGaD
Imipramine—CYP3A4—Metabolism—APOE—epilepsy syndrome	1.39e-07	3.38e-06	CbGpPWpGaD
Imipramine—ADRA1D—Signaling Pathways—AKT1—epilepsy syndrome	1.37e-07	3.33e-06	CbGpPWpGaD
Imipramine—SLC22A1—Metabolism—AKT1—epilepsy syndrome	1.32e-07	3.22e-06	CbGpPWpGaD
Imipramine—CYP1A2—Metabolism—PTGS2—epilepsy syndrome	1.23e-07	3e-06	CbGpPWpGaD
Imipramine—CHRM3—Metabolism—AKT1—epilepsy syndrome	1.22e-07	2.97e-06	CbGpPWpGaD
Imipramine—HTR1A—Signaling Pathways—AKT1—epilepsy syndrome	1.19e-07	2.9e-06	CbGpPWpGaD
Imipramine—CYP3A4—Metabolism—POMC—epilepsy syndrome	1.19e-07	2.9e-06	CbGpPWpGaD
Imipramine—HTR2C—Signaling Pathways—AKT1—epilepsy syndrome	1.19e-07	2.89e-06	CbGpPWpGaD
Imipramine—ADRA1B—Signaling Pathways—AKT1—epilepsy syndrome	1.13e-07	2.77e-06	CbGpPWpGaD
Imipramine—CYP3A4—Metabolism—ALB—epilepsy syndrome	1.09e-07	2.64e-06	CbGpPWpGaD
Imipramine—CYP2B6—Metabolism—AKT1—epilepsy syndrome	1.05e-07	2.56e-06	CbGpPWpGaD
Imipramine—DRD2—Signaling Pathways—AKT1—epilepsy syndrome	1.05e-07	2.55e-06	CbGpPWpGaD
Imipramine—HTR2A—Signaling Pathways—AKT1—epilepsy syndrome	1.03e-07	2.51e-06	CbGpPWpGaD
Imipramine—CYP2E1—Metabolism—AKT1—epilepsy syndrome	1.03e-07	2.51e-06	CbGpPWpGaD
Imipramine—HRH1—Signaling Pathways—AKT1—epilepsy syndrome	1.03e-07	2.5e-06	CbGpPWpGaD
Imipramine—CHRM1—Signaling Pathways—AKT1—epilepsy syndrome	1.02e-07	2.5e-06	CbGpPWpGaD
Imipramine—CHRM3—Signaling Pathways—AKT1—epilepsy syndrome	1.02e-07	2.49e-06	CbGpPWpGaD
Imipramine—CHRM2—Signaling Pathways—AKT1—epilepsy syndrome	1.01e-07	2.46e-06	CbGpPWpGaD
Imipramine—ADRA1A—Signaling Pathways—AKT1—epilepsy syndrome	1.01e-07	2.46e-06	CbGpPWpGaD
Imipramine—CYP3A4—Metabolism—PTGS2—epilepsy syndrome	9.49e-08	2.31e-06	CbGpPWpGaD
Imipramine—CYP2C19—Metabolism—AKT1—epilepsy syndrome	7.93e-08	1.93e-06	CbGpPWpGaD
Imipramine—ABCB1—Metabolism—AKT1—epilepsy syndrome	7.74e-08	1.89e-06	CbGpPWpGaD
Imipramine—CYP2D6—Metabolism—AKT1—epilepsy syndrome	7.3e-08	1.78e-06	CbGpPWpGaD
Imipramine—CYP1A2—Metabolism—AKT1—epilepsy syndrome	6.18e-08	1.51e-06	CbGpPWpGaD
Imipramine—CYP3A4—Metabolism—AKT1—epilepsy syndrome	4.77e-08	1.16e-06	CbGpPWpGaD
